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ABSTRACT
The a c t i v i t y of mi n imal constitutive e nhancer (MCE)
(n ucleotides 76 57-7870) c,f hu ma n papillomavi ru6 11 was s t u d i e d
i n undiff erentiated and r et i no i c acid-differentiated P19 mous e
emb r yo n a l c arc i n oma cells . The enhancer was active in RA-
differe ntiated cells but no t i n und ifferentiated cells . The in
vivo activity was corr Ala ted wi t h in vitro DNA-protein
i nteractions by oseeer protection assay . Four prot e c t ed
regions (I -IV) we r e d et-ected with RA-differentiated nu c l e a r
extracts, while protection wa s obser ved with undiffe rentiated
nuclear extra cts f or the reqions III and I V. To f ur t h er s tudy
the f unc t i ona l i mportanr:e o f the protected regions, de letion
mu t an t e nhancers were tested fo r their i n vivo act i v i t y ,
" utan t en hancers we:::'EI act ive like wild type in RA-
d i f f ere nt i a t e d but not Ln undifferentiated c ells . De letion of
protected region I and a, 9 base pair sequence o f tbe imperfec t
NFl palindrOllle of pr-c t.ect.ed region II of HPV11 MCE displayed
activity c l os e t o that of wild t yp e HCE. This suggests that
t he major constitutive enhancer activity is exhibited by t he
minimal sequences of xes (nuc leo tide 7785-7870) in Pig RA-
differentiated cells. rhe mutant enhancer (n ucleotide 78 11 w
787 0 ) which l os t both protected regions I and II showed o nly
50\ of the wild type activity . Th i s indicates t h at sequences
displaying major ccnsrt Itar t.Ive activity of HPVll NCE are
present i n the pr ot ecte d r egion I I , a l though funct iona l
syner gism a p pears t o be i mportant f or ful l activity o f t h e
e nha nc er . Th e r o l e of ent i r e prote c t ed r egion I I by i t se l f
i nc luding t he 9 base pair s equence whi ch wa s deleted in t he
mi ni ma l enh a nc er sequences, was exami ne d f or i ts in vivo
act ivity . Th e protected region II alone s howe d s u bstantial i n
vivo a ct i vity in RA- d i fferent i a t e d ce lls whi ch wa s 90 -fo l d
highe r than the res idua l act i vi t y ob s e r ved f or
undiffer~ntiated cells . The in vivo activity of pre e ec ced
reg ion II i n RA-di f f erent i ated-dep endent manner wa s correla t ed
wi th in vi t ro DNA-prot ein i nteractions. Th e protected region
II showed an extra DNA-prot ein compl e x with RA- differe ntiated
nuclea r e xt r a cts i n t he ge l r etardation a s say . Th e f or mat i o n
of thi s complex was competed by t he imperfec t . NFl pa lindr omi c
s equ ence s but not by the NFl half-s ite s equence o f protected
region II . This su gges ts that cert ain f acto r( s ) i n RA-
d iffer f!ntla t ed cells specifically b i nds the imperfect NFl
palindrome . The DNA-prote in i nt eract i on wa s speci f ic f or HPVl l
imperfect NFl pa l indrome a s the c ompl ex f orma t i on was not
abolished e ither by poly oma J C v i r us per f ect NFl palind rom e o r
its mut ant s eq uence. This s uggests the existence o f f a mi ly o f
NFl proteins in Pl 9 RA-di f f erentlated cells t ha t sho w
different bind i ng sp ecificities fo r the NFl binding s e que nces
of i mp erfec t and perfect palindromi c nature . As the ex t r a RA-
differentiated DNA-protein c omplex ....as s pec if ic f o r the
imperfect NFl palindrome , UV cross-linking was performed to
determine the number of proteins interacting with it . At l e a s t
s i " proteins were found to interact with the imp erfect NFl
palindrome and three of them were specific for RA-
differentiated nuclear extracts . The exact nature and bind ing
sites of these three proteins for the functiona l i mportance of
protected region II in RA-differentiated ceI t.s require further
i nvestiga t i on.
iii
ACKNOWLEDGEMENTS
I am extremel y indebted to both Dr . Ve r na Ska n es ,
As sistant Dean, aeeee r c h and Gr aduate Stud ies, Fa culty DC
Med i cine and t. h e s u p e rviso r y committe e member Dr . Banf ield
You nqhusband whose time l y help , s u p p ort and inva luable
suggestions e nc ouraged me to give a shape to this thesis . t
express my s i n c ere grat itUde t.o my superv i sor Dr . Mary Pate r
f or he -r ; <.t i d a nc e during research work a nd thesis preparation.
I am very much grateful to Dr . Gary Paterno for serving a s
supervisory committee member and for his in valuable comments
on t h e draft of th i s thesis. I would l i k e to thank Dr. Alan
Pa ter fo r his guidance during r e s e ar ch wcr-k,
I am very much. thankful to my colleague and friend, Kot l a
Umesh Kumar not only foX' reading the draft of t his thesis but
also for his help i n many ways . I thank my colleagues Dr .
Rakesh Mltt a l. Dr . Be l agu l i, !{aghuram and Mi s s . Christine
Ki saka. I t han k Rao P. Varada for his he lp in preparing the
figures . The compa ny of Umesh Kumar, Balaj i ge Lase , uevt
Reddy, Srinivas Dendu l uri, Narayanan Ra jgopal , Annaji, Or .
C.V .V Prasad and Dr. K.S .R . Prasad is high ly appreciated.
I he r -eby ackno....l e dg e the encouragement given by the
professors in India, Dr . T . Suri babu , Dr . Kr ishna Swamy and
Or . P . Rama neo . My specia l t h a nks are to my lr i e nd Dr .
Suryana rayana Vulimir i (Houston) fa::: h i s moral support .
The lack of vocabulary fails to express the s t upe ndous
weight of my heartfelt gratitude for t he mora l support
ex tended by my parents, my loving and caring wi f e srilakshmi ,
my brothers Giri and Kanth, my s isters Van ! and Anu, brothers -
in-law and sisters-in-law . I remember the memory of my uncle ,
l a t e B. Rama Rao withou t. his he l p I would not ha ve got t he
ne c e s s a r y education for the h i gh er studies.
La s t but not least , the fi na ncia l s upport p r ov ide d by t he
Sc hool of Graduate Studies and Faculty o f Hed i c ir,e throughout
my study period is highly acknowledged .
TABLE OF CONTENTS






Li st of figures . . . . • . . . . . . . . . . . . . • • . x
Li s t of tables . . . . . . • . . . . . . . . . . . . . xii
List of abbreviations . . . .
CHAPTBR 1 INTRODUCTION . • •
. . . . . . . . . . . x i il
1. 1 Transcriptional c ontrol in euk aryotes
1 . 1. 1 Regulatory elements . .•. . . .
1 .1. 2 Gene ra l trans criptional mach ine r y . . . 4
1. 1. 2 . 1 TFII D as t he f irst ge neral
transcr iption factor to i nteract wi th
the promoter . . . . • • . • . • . . 5
1.1.2 .2 Other ge neral transcripti on factors
necessa ry f or transcription pre-
initiation comp lex . . . . . . . . . 6
1.1.3 RNA po l ymera s e II • •• • • • • • . • . 8
1.1. 4 Tra ns criptiona l ac t ivators and repressors
modulate the levels of tra nscript i on • . 10




1 .1 . 5 Role of coactivators and different
TFIID comp lexes for transcriptional
ac t i va t i on . . . • • • • • • . . • • 15
1. 2 papillomaviruee s. . . . • . . • . . • . . . . 16
1 .2.1 Genomic organization o f
papillomav iruses . . . . . . . . . • • 18
1 . 2 . 2 Role of viral and cellular f a c t or s in
t he oncogenicity of human papilloma-
vir us e s • . • . . . . . . . . ,.
1 . 2 . 3 Noncoding regions of human
papi llomaviruses 16 and 18 • . • • • • 21
1. 2 . 3 .1 Tra ns criptional r e gUl a t i on by HPV16
enhancer e lements . • . . . . . . 21
1 .2. 3 .2 Transactivation and r epress i on by
enhancer ejementis of HPVl8 • • . • 2 6
1.2 . 4 Huma n pap !llornav i rus 11 (HPVll) . . . 3 1
1.2 .4 .1 Role of genomic alterations i n t h e
o nc ogenic potential of HPVll . . 32
1.2 .4.2 Tran s c r ipt i onal z-equ La t Lcn by
enhancer e lements of HPV11 • . 33
1 .3 Role of r e t i noid s . . . . • . • • . . . . . . 40
1. 3.1 P19 mou se embryonal c a rci noma c e l l s • . 41
1 . 4 Statement of the research pr ob l em • • • • • . 43
vii
cnPTn 2 KATBRIALS AND XETHODS • • • • • • • . .. 4 5
2 . 1 Materials. . . . • . . . . . . . . . . . 4 5
2 .2 Recombinant p lasmid constructs. . . . . 46
2 .2 . 1 Construction of deletion mutant
plasmids . . . . . . . . . . . . . . . 49
2 . 3 Cel l cu l t u r e of P19 mouse emhryona l c ar c i no ma
cells . . . . . . . . . . . . . . • . . • . . 5 2
2 . 4 Transfection of und iffe rentiated and retinoic
acid-differentiated ce lls . . . . . . • . .. 52
2 .5 Harvesting the cells a nd preparation o f cell
lysates for CAT assays • . . . • . • .. . 5 3
2.6 Chloramphenicol acety l transferase (CAT)
assays . • . . . • . • . • . . . . • . . 54
2 . 7 preparat ion of nuc lea r ex t racts . . . . . . . 5S
2 .7. 1 preparation of nucle i . . • . • . . 55
2.7.2 Nu c l ear ex tract pr a pa r a t i on . • . • 5 6
2 .8 Preparation o f radiolabeled DNA pz-crbea for
in vi tro assays . . . . . . . . . . . 5 7
2 .8. 1 co mpetitors used i n t he ge l
retardation assay . . • . • . . . . . . 5 8
2 .9 Protocols for in vi tro assays . . . . . . .. 5 9
2 .9 . 1 DNa s eI protection assay
2.9 .2 Gel reta r da tion assay .
5 9
61
2.9 .3 uv cross-linking . . . . . . . . . .. 61
viii
CHAPTU 3 RBSULTS . . • • . . • • • • • • • • • • • • • 64
3. 1 Activit ies of enhancers of HP V l l, HPV16 and
HPVIB in u ndifferentiated and retinoic acid-
differentiated Pl9 ce lls . • . . • • . • • 64
3 .2 corre l ation of in vivo activity of HPV 1 1
HCE with in vi tro DNA-p r ot ein interactions . • 68
J. ) The role of protected regions in the in vivo
funct ion o f t he e nhancer. . . . • • • • • 74
l den t ifi;:-a tion o f factor(s) binding t o the
protected region II de termined by gel
retardation assay . . • . . _ . . • . . 78
3 . 5 Proteins i n t eracting with nne i1npe rrec t NFl
palindromic sequences as show n by
uv cross-linking . . . . . • . . • • • •• •• 8 1
CIlAPTBa... DISCUSSION . . • • • • • • • • • • • • • • • 85
4.1 Diffe r ences observed fo r the enhancer
activities of HPVs in RA-d ifferentiated
cells . • • • . • . • • . • • • . . • . • . 86
~ . 2 Cor r e l ation of in vi vo act i vit y of HPVl 1
HCE with in vitro DNA- protein intera cti on s . • 88
4 .) Funct :..ona l i mpor t a nce of the protect ed
regions . • . • • . • • . . • . • • . . • . . 89
4.4 Cor r e l ation of i n v i vo act i v ity of prote cte d
r egion II with i n vitro DNA- p rotein
Ix







Figure 1 . Schematic representation of different
enhancer elements of HPV16 noncod ing region
a nd the interacting t r ans cr i pti on factors. .23
Figure z , Diagramatic representation of cons t itutive
and inducible elements of HPVla and
DNA-protein interactions . • . . • . . . . . 28
Figure 3 . Linearized map of HPVI1 • • • • • • . • • • 34
Piqure.. . constitutive , inducible an d cell-specific
enhancer elements of HPVi l . . . . . • • • • • 37
Fiqu r e 5. Physical map of t he r ec ombinan t HPVll enhancer-
CAT plasmid construct , pTl • • • • • • • • • • 47
Fiqure 6 . Activities of t he mi nima l constitutive
enhancers of HPVll , HPV16 a nd HPV18 in
undifferentiated a nd RA-differentlated PI 9
EC cells • • • • • • • • • • • • • • • • • 65
Flqure 7. DNaseI protection assay of t h e minimal
consti t utive en hancer (HCE) o f HPVll • • 69
Figure 8 . CAT activities o f t he deletion mutant CAT
co ns tructs of HPVll MCE i n RA-differentiated
cells shown i n relation to t h e protected
reg i ons observed f or HCE . . • . • • • . • • • 75
Piqure 9 . I nteractions of cellUlar factors with the
xi
protected region II shown by gel retardat i on
assay • . . • . . . . . . . . . . . .
Piqure 10 . Proteins of undifferentiated and
RA-differentiated nuclear exta-ect;s
interacting with the imperfect NFl palindrome
shown by uv cross-linking . . • . . . . . . . . 82
xii
LIST OFTABLES
Tabl_ 1. CAT activities of HPV enhancer-CAT constructs
in UD and RA-differentiated PI9 cells . . . 67
Tabl_ 2 . Protected sequences of the HPV 11 mi n i ma l
constitutive e nhanc e r using PI9
RA-d ifferentiated nuclear extract s and their
homology to known transcription f a ct or binding
motifs •• • . .• • •• • . •... . .•. . 7 2
xiii
LIST OF ABBREVIATIONS
API Activator protein 1.
bp b a s e pair s
BPVl Bovine p apil lolll.80virus 1.
BRL aeenesaa Research Laborator ies
eSA Bovine serum. albumin
BUDR Bromodeoxyuridine
c els iu s
CAT Chloramphenicol acetyl transferase
eDNA complementary DNA
C/ EBP CCAAT/ Enhancer binding protein
CTF CCAAT-blnding t r a ns c r i pt i on facto r
DNA Deoxyribonucleic acid
DNase I Deoxyribonuclease I
dNTPs Deoxynucleotide trlph osphates
OTT Dithiothreitol
EC Embryonal carcinoma
EDTA Ethylenediaminetetra-acetic ac id
HPV Human papi llomavirus
kb Kilo base pairs
kd Kilo daltons
MCE Mini mum constitutive enhancer




NFl Nuclear f ac t o r 1
MFA Nuclear factor I-associated factor
ORF Open reading frame
PAGE polyacrylamide gel electrophoresis




SOS sodium dodecyl sulfate
SV40 s iDlan virus 40
TAF TBP-associated factor
TBP TATA box-binding protein
TEF Transcription enhancer factor





.LJ. 'fRANBCR:I P T IONAL CONTROL IN EUlAB Y OTE8 :
~ Regulatory ereceeaee e
In eukaryotes, regulation of mRNA sy n t he sis i s e n
imp o r t ant mea ns t o r egu l at e gene ex press ion . Th e f r eq uency o f
i ni t i ation of mRNA synthes is de pends upon different
cha r a cte r istic c is~regulatory el eme n ts that modulate the rate
of t r anscript i on of ac tive genes . Th e regulatory elem ent s t h u s
identified are called promot e r elements a nd enhancer elements .
The promoter e l e ments ar e t he r egula tory eleme n t s that
determine the s i t e of i niti ation and ar e r.esponsible for bas a l
le ve l s of trans cri ption . The enhancer e leme nts increase or
re duce the rate of transcription from the promoter . Thes e
elements a re located a t distant positions f r om the p r ollot e r
eleme nts ( n yna n, 1989; Mitchell a n d Tjian, 1989; He r na nde z ,
1993 ) •
The p r oJ\oter elemen t s in eukaryotes were first identified
for chicken ova lbumin a...... adenovirus-2 majo r la te genes
(Ga n n on et al. 1 979; Corden et al . 1980 ). The p r oJ\ote r
eleme nts h a ve an AT·rich reg ion, TATAAAdesignated as the TATA
bOK located at 25 - 30 bas e pa i r s ups t ream from t he start site o f
i ni t iatio n of trans cr ipt i on, and one or more sequence e l emen t s
of 8-12 basep airs designated as upstream promoter elements
(UP Es) . So me of the upstream promoter elements have CCAAT
box e s and GC boxes located from 3 0- 110 ba sepairs upstream of
the star t s i t e o f initiation of transcription. Th.e OPEs act
regardless of their orientation with respect to the TATA box .
The str eng t h of UPEs depends upon the number and t y p e of UPEs.
The CCAAT boxes and GC boxes are known to bind t r a ns crip t i on
fa ctors wh i ch modulate the t rans cription car r ie d out by the
general transcriptional machine ry (Man i atis e t al. 1987 ;
Mitchell and Tj ian , 1.989).
A simple funct-.ional promoter element kno wn as an
i n i t i at or (lnr) was identified within the transcription start
si te f or tho lymphocyt e -speci f ic termina I
deoxynucleotidyltransferase gene which l acks a TATA box . The
in i t i ator element specifies t he start site for i n1 tiation of
transcript ion for those genes lacking a TATA box (Smale and
Bal timor e , 1989 ) .
The enhancer e l e ment s ccnee In modules of discrete DNA
seq u e nce motifs t hat specifically interact with activator or
repressor pr oteins . They were first identified i n SV40 virus
by Banerj i at a1 . (19 8 1) . The enhancer elements c a n act over
long di s t ances a nd are orientation independent. Some modules
of enhancers , for example, those of the heat-shock regulatory
el e men t can not act from a distance but are act i ve when they
ar e tandemly duplicated. The principle of tandem duplication
c a n not be applied to a l l r egulator y e l emen t s since mUl tiple
c o p i es o f UPE CCAAT box do not s timulate transcription a t e
di s tllinc e . St ructurally UP Es a nd enha ncers are simi la r bu t
t here a re operational differences based upo n the n umbe r an d
a rrangem ent o f transcription factor recognition sequences . The
enhancers th at respond to e nvironmental stimuli suc h as t h o s e
f or heat shock, he a vy metals , vira l i n f ection , growt h f actor s
o r horm ones are c a l led inducible e nhancers . The inducible
enhancers were identified , fo r exam ple , for genes of
me tallo thionein, l3- in terferon , heat-shock proteins , e-ros,
s teroid hormo ne respons i v e enhancers of mouse mamma r y tumour
virus a nd ma l oney mouse s arcoma virus and the glucocorticoid
res ponsiv e en hancer elemen t (GRE) of h uman papillo mavirus 16
(Maniat is et ez , 19 87 ; Mitchell and Tjian , 1989 ; Gloss a t al.
19 8 7) .
The enhancers which are a c t ive only during specific
d evelop menta l sta;,jes or only i n specific t i s su e s are called
t em poral and t issue-specific enhancers r e s pect i v e l y . For
example , immunoglobulin g enes h a ve a-c era s pe c i f i c e nha nc e r s
wh e r ea s enhancers for some Drosophila ge nes a r e ac tive onl y in
d i. f fer ent tis sue s and a t different s tages of f r uittly
d e velopme nt (Maniat is at al . 19 87 ) .
The cis-actin g regulatory eleme nts i n yeast a re known
a s upstream a cti vati on sites (UASS) and have properties wh ich
a re similar t o manmlal1a n e nhancers (GUilrente, 198.1) .
Some of the cis-acting elements known as silencers were
identified in the repetitive sequences of the rat insulin
gene. These sequences can block the acti vity of enhancers
(Mit chell and Tjian, 1989; Lai mi ns at al. 1986) .
.L..L.2. GENERAL TRANSCRIPTIONAL MACHINERY;
Thr ee d ifferent RNA polymerase enZYJIles n amely RNA
polymerase s I, II and I II carry out transcription of different
s e ts of gene s in euka ryo t es . Messenger RNA (IlIRNA) synt he s is
cannot be carried out by RNA polymerase II alone but rather
requires a set of transc ription factors ca lled 'g eneral
transcri pt io n rectcr- (GTFs). RNA polymerase II alo"J with
GTFs are nece ssary for basal levels of transcription.
Tr anscription i s activated or repressed by sequence-specific
factors bind ing to the recognition sequences of upstream
promoter elements and enhancers. Weil at al. (1979 ) observed
that purified RNA polymerase II cannot initiate transcription
unjese t he i n vi t ro system is supplement ed with crude nuclear
extrac t s rich i n different trans cription factors.
Subsequently, se ven general transcription factors known as
TFII A, B, D, E, F, Hand J were identified . with the
exception of TFIIJ, all other GTFs were purified to
homoqeneity and the cDNAs encod ing TFII B, D, E and F were
cloned (Hoffmann at al. 1990; Ha at al. 1991 ; Peterson a t al.
19 91; sopta et al. 19891 Finkelstein et al. 1992) . TFIID is a
trIultiprote in complex c omposed of TATA-box b ind ing protein
(TBP) and TBP-associated factor s (TAFs) . The TBP encod ing
ge ne s were cloned from different organisms and are h i ghly
similar (Hernandez, 1993 ) . T BP along with RNA polymera se II
an d other GTFs c a n mediate oa se j, t ranscript ion whereas TFIID
i s ess e nt i a l to respond to t rans cript iona l activators . In
order t o form a preinitiation c omplex , a l l the GTFs along with
RNA polymera s e II as s emble at t he TATA box for i nitiation o f
t r a n s c r i ption l i ke the f ormation of close d co mp l ex at
bacteria l promoters (Hernande z , 199 3; Ham e t a l . 1992 ; Zawe l
and Reinberg, 19 92; Dynlacht e t al . 1991; Ta ne s e et al . 199 1 ) .
TFIID as the lirst general transcriptional faotor
to interact with the promoter:
TFIID is the first general transcription fa c t or whi-:h
recognises and binds the TATA box in a s e que nce -sp ec if i c
manner. TFIID is a 750 kd mu l tipr o tein complex c ompo s e d o f a
38 kd ( in hu mans) TATA-box binding protein (TOP) and e i g h t
polypeptides known a s TBP-associated f actors (TAF s ) of
a ppr o xima t e l y 250, 150 , 12 0, 1 00, BO, 75 , 65 a nu 60 k d (Pugh
a nd Tjian, 1992; Hisatake et az . 1993). The TBP a nd TAFs are
phy sically associ a t ed forming t he TFIID co mplex . TBP brings
ba sal l evels of t.:,:,anscription, whereas TAFs a re ne cessary for
transcriptional ac t iva t i on by the activators . The TBP haa a
conserved carbo xy-terminal domain and ha s 180 basic ami n o
acids . Th is domain i s 80\ identical i n d iff erent organisms .
The c~terminal domain is essential for determining s pec ies
specific i ty , DNA-binding a n d response to tran scr i ptional
activation signals . The C~terminal domai n i s rich i n l ysine s
and can f orm an a - he l i x which is i mp or t an t fo r prot ein-pr ot e i n
i nteractio ns and DNA-binding (Hoffman at er , 1 9 9 0 ; Cormack at
a1. 1991; Reddy and Hahn , 19 9 1 ; Hernand e z , 1993 ) .
Zhou at ez , (1993) cbe e z-ved t hat t he c-termina l domain
interacts wi t h two major TAFs . Such an interact i o n sup p orts i ll
vitro transcrip tional stimulation by d iff erent ac t ivation
domains and ca n even su ppo r t transcript ion f r om TATA~less
pro moters. TFI I D binds in t he mi no r qr cc v e of DNA and induces
DNA bend i ng whi ch may f acilitate fo rma t i on of the
pre initiation compl e x a n d int eractions wit h other
t ra nscrip tion f acto rs (Horikoshi at a1. 1992; Lee et a .z , 1991 ;
Starr and Hawle y , 1991). TB P is required by a ll three RNA
pol ymerases as we ll as for tran sc ription from TATA-box l ackin g
promo ters (Her nandez, 1 99 3 ; Cormack and Struhl , 1 992 ; Zhou a t
81. ~992 ; Zenzie-Greg o ry et e z . 1 9 9 2 ) .
ot he r genera l transoript ion fac tors n.ausary for
t ranscription preinitiation c ompl e x :
TFIIA bi nds t he pr omoter a f t er TFIID bi ndinq and
stabilizes t he TFU O-D NA i n teraction gener atinq the TFIIDA
complex a t t he promoter . It wa s hypothesized that t his ca us es
eome conformat i ona l change i n the promoter DNA after i ts
binding t o TFIID. TFI Il\ is an heteromer co mpos ed of 3
polypeptides of 34 , 19 and 14 kd CReinberg a t a .l . 19B 7 : cortes
et al . 1992).
TFIIB binds to t M TFIIDA complex f or me d at the TATA box
p r ovh" ing a scaffold for .. .re binding of RNA polymerase II . The
eDNA e ncoding TFIIB was cloned. The cDNA sequence indicates
t h a t i t encodes a protein composed of a 7 6 amino acid r e peat
at its c-terminal do main and a hydrophilic tail a t t he N-
terminus . The c-terminus co n t acts DNA whereas the tail
participates in protein-protein i nteractions . It wa s observed
that an acidic activator VP16 i n t eracts with the N-term inus of
TFIIB Ctia at al . 1991; Li n and Green, 1991; Lin et al. 19 91) .
TFI I F is a heteromeric factor also known as RNA
polymerase II-associat ed factor 3 0/7 4 (RAP 30/74) . It co n s i s t s
of two polypeptides of 30 an d 74 kd whose cDNAs we r e cloned .
The smal l subunit of TFIIF L.e . RAP 30 recru its RNA po lyme rase
II to t h e TFIIDAB c omplex a nd prevents non-specific binding of
RNA polymerase II t o DNA . It was thought to playa role in the
u n wi ndin g of DNA s trands since it has ATP-dependent helicase
activity. The role of RAP 30 1s remin iscen t of the
characterist ics of bacterial sigma factors ( Sopta e t al. ~ 9 8 9 ;
Greenb l att , 19 91; Flores et ez • 1991; Killen a nd Greenblatt ,
1992 ; Aso et ez . 1992; F inke lstein at ar . 1 992) .
TF IIL enters t he TFIIDAB .POLII.F complex a nd is important
for the formation of a s table p rei nit iat ion complex. It is a
heteromer of 57 kd TFIIEa a nd 34 kd TFI IEjL Th e cCNAs encod i ng
both of the s e s ubuni ts were clo ne d . Th e sequenc es i nd i cated
that TF IIEa ha e l eu c ine r epe a t s , ed nc finge rs and helix-turn-
helix motifs wher-eas TFI I{J has c ha racter istic seque nce motifs
found i n ATPases a nd he l i cas es . These fea t ur es of TFIIE a and
P suggest that t he y are i mportant for its i nteractions with
DNA as we l l as RNA polymer~se I I and other GTFs (Peterson a t
a1 . 1991; Sumimoto et ej. 1991 ; Ohkuma e t a1. 199 1) .
Th e identity o f transcription factor TFIIH wa s
established as a multis ubu nit f actor cons i sti ng o f 5
polypept i de s (92 , 62, 43, 40 a nd 3 :! kd) . It was observed t ha t
TFI I H can ph osphor y l a t e t he ca r boxy- termina l doma i n o f lU 1J"
p o I ymer-a ne II but i t is not known which subuni t ha s t he k i nase
prope rties . TFIIJ i s a n activity k nown t o enter the
preinitiation co mp lex after TFI I H (Lu at a1. 199 2 ; Flor e s e t
a1 . 1992) •
.!.......!..... RNA polymerase IX:
This is a 8-10 s ubunit e nz yme ab le to polymer i ze
ri bon uc1eotides into mRNA us i ng II, DNA t e mplate by i ntera cting
with GTFs a nd elongation factors . I t f unc tions pe r ha p s I n
conjunction with o ther enzymes su ch as be l leases a nd
t opo i s ome r a s e s . The in vivo act i vity o f RNA po l ymerase I I was
attributed t o i ts l argest subun i t of 240 kd whi ch ex ists as
phosphorylated, nonphosphory lated a nd degraded fOI 'ms (Cor den
et a1. 1985 ; Saltzman and Neinmann, 1989).
Th~ l a r ge s t subunit has a distinct s tructural domain
called t he carboxy-terminal domai n (CTO) or ' t a il ' wh i ch
consists of tandem repea ts of a seven amino acid consensus
seque nce . The 7 amino acid repeat va ries in number in
different o rganisms . This seems to be related to t he
comp lexity of the organisms . The CTC ....hich is u n i que to
eUkaryotes has 52 repeats in mammals . Most of the current
r e s e a r ch related to po lymerase I I is focussed on the CTC since
e TC wa s found t o be essentia l for cel l viabilty (Corden at al.
1985 ; Saltzman and weinmann , 1989 ; Corden , 1990).
The CTC of the nonphosphorylated form was found to be
phosphorylated by TFI IH ....hen RNA p o l yme r a s e II is present i n
the preini tiation complex (Lu at a1. 1992) . Previous ly it ....as
obs erved that phosphorylation brings a conformational cha nge
in the CTC ....hich i s essential fo r transcription initiation
(Cadena an d Cahmus, 19 87 ; Zhang and Corden, 1991). But recent
find i ngs from seriza'ola a t a1 . ( 1993) indicate t hat
phosphorylation an d basa l levels of transcription arc no t
coupled . They point out t ha t probably al l the essentia l GTFs
a nd so me unidentified factors may be important for CTO-
phospho rylatbn r elat ed transcription initiation .
Studies using a r e c ons t ituted t r a ns c r i pt i o n system s howed
fu nctiona l evidence that CTC i nteracts with high molecular
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fo rm. TFIID f or the f o rmatio n of preinitiatlon co.plex (Conway
a t a l . 1992 ) . The all i no t e rm i na l domai n of RNA po lymerasll II
ha ving zinc f I ng er motHs was thought to be i nvo l ve d i n DNA
binding . But the model proposed by Suz u k i ( 1990) s ugge s ts that
CTD forms 8 - tur ns and b inds by intercalating with DNA.
L...l..d Tr a n s c r i ptio nal activators and repressors modulate
the leyels ot transeriptiop;
Var ious DNA binding pr ote i ns were i d ent i f i ed in
euk aryotic ce l l s a nd found to b in d s pe cific seque nce mot ifs of
t he cis- regulatory e lellle nt s t h e r e by modulating the l e v e l s of
transcription . DNA binding prote i n s can be grouped int o fou r
lalll i lies ba s ed upon thei r DNA-binding do mains name l y z inc
f i ng e rs , l e ucine zippers, ho meo domaina and basic amino ll.cid-
ric h CCAAT box bind ing domai ns (Pa ba and Sa uer , 1992 ; Mi t che ll
and Tj ian,l989) . For example, t h e s teroid , t hy roid and
ret inoi c ac id receptors , GAL4 a nd SP l have zinc finge r domai ns
whereas t h e t ranscription f act ors API a nd C/EBP hav e leucine
zip pe r s. CTF/ NFl bind s t o t he CCAAT motifs. Factors l ike Oct- l
and oc t ez have hcn eodcee Ine , Some proteins s uc h as lIIuscle
cel l-specif ic HyoO, upstream s timU lat ory fact or (USF ) and C-
Hyc have he lix-loop-helix(HLHl motifs . Th e s e proteins bind DNA
by either dimerization or heter omeriza t i o n . Th ere a re number
of other DNA bind in g prote ins such liS SV40 l arge T-a nti g en,
t r a nscrip t i on e nhancer factor (TEF) , pap i lloma vir u$ £2
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protein , TFI I D and human p5J tumour suppressor gene product
which do not co me under any pa r t i c u l a r family (Mi t che ll and
Tjian , 19 89 ; Herr, 1991; Ha r r i s on , 199 1 ; Co l e , 1991).
Transcription factors ac t ivate transcription by
po s s e s s ing different transactivation doma ins such
g lutamine-r ich (SPl), pro line-rich (CTF/NFl) and acidic amiJ'lo
acid-rich (VP16) domai ns (Sig l er , 19 8 8 ; Mi t c h e ll a nd Tjian ,
1989; Ptashne and cenn, 1990) .
Some o f the tra ns c r ipti on factors s uch as API ca n al s o
act as repressors by direct ly competing for t he sam e sequence
element recognised by g lucocor t icoid and ret i no ic ac id
recept ors. Repression ca n also be due to mutual inhibition of
DNA binding of API and g lucocorticoid receptors t h rough
protein-protein interactions (Schule et al . 1990a i Sc hu l e e t
ef . 1990b j Yen et al . 1990) . Active tra n s c r i p t i onal repressors
l i ke human kruppel-related factor YYl d i r ectly downregu l ates
t ranscription (Shi et e f • 1991) . A novel repressor of 19 kd
known as Dr1 is phosphory lated an d i nteracts wi t h TBP t he r e by
inhibit ing the association of TFIIA or TFI I 8 wi th TBP , leading
t o t he repression o f both ba sal and act ivated l evels of
transcription (Inostroza et al . 199 2).
Currently, research on transcription factors is focussed
on how cell specificity i s co ntrIbuted by different c Ieeue -
specific transcript ion f a ctors a nd t heir coact iva tors . For
example , pr e v i ously it was thoug ht that 8-ce l l s p ec ific Oct-2
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impo rtant for transcriptional activa tlon from
imlllunoglobulin pr emc eee a . Recent studies s ho wed t hat a t i s s ue-
specific, promoter-specific a nd oce-a a nd Oc t -2 specific
coactivator , OCA-B , mig ht be t he major dete r mi nant for B-cell
specific t ranscription of immunog lobulin promoters. But t he
quest ions t hat arise are whe t her Oct-2 i s physiologically
importan t for t he activation of transcript ion by OCA-B and
whe t he r th'!re are any additional sequence requi rements that
determine the 8-ce11 s p e c i f i c f unction of Oct factors a nd
their coactivators (LUO at a l . 19 9 2 ) .
Three princi pal mode ls have been proposed for t he
po sitive regUlation of t r a ns c r i pt i on factors . The DNA- loop i ng
mode l is most favoured . Th is mode l is gaining impo rtance since
i t was de monstrated t h a t t he fac tor, SP1, activa tes
tran s cript ion t hrough prote i n-protein interactions when the
i nt er ve n i ng DNA l oop s out (S u et al. 1991) •
.L...L!...t.l. C'l'l/Nll family of transcription factors :
Tne se qu e nc e s (G) CCAA (T) and TGG (A/ C) Ns GCCAA
important regu l a tory elements f ou nd in the regUlatory region
of a number of RNA pcLymer -aee II - r egul at e d c e l lular a nd vira l
ge nes. The factors t ha t b ind the s e sequences and regUlate
transcription a re known as CCAAT-binding t ranscrip tion f ac t or s
or the nucle a r factor 1 (CTF/NFl) family of proteins
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(Rosenfe ld and Kelly, 19 8 6 ; Jones a t .'1 . 1988; Mi tche ll and
Tj ian, 1989).
Several dist inct proteins exist as CTF/NFI in eukaryotic
cel ls . These factors ca n be encoded by the same gene by
differentia l RNA splicing giv i ng rise t o p r ot e i n s o f 52 -66 kd
as obs erved in human HeLa cells (Sa n toro a t al . 1988 )
Diff er ent genes e ncode CTF/NF I prot eins of 29-33 kd in chicken
liver t i s s u e (RUpp at al. 19 9 0 ). Sequence alignments of
d ifferent CTFj NFl proteins revealed certain conserved domains
despite t h e differences observed i n t h e ami n o-terminal a nd
ca rboxy-termina l domains (Me r Jllad at al . 1989 ; Rupp a t e i ,
1990) . At least 6 x 1 0· NFL b ind i ng sites were estimated t o
e xist i n t he nu.aa n ge nome (Gro nostajski at al . 1984).
Jones at a1. ( 1967) purified NFl. t o h omogen e i t y a nd
observed t hat NFl ac tivates adenovirus gene t r a ns cri p t i on a nd
stimulates ade novir us DNA r eplic a t i on i n vi t ro . Later on i t
\-14S observed that t he doma i ns r espon s i ble fo r transcriptional
activation and rep lication ar e d iff er e nt . The positive l y
charged N-terminal domain was fo u nd to be respo ns ible to r DNA
bind i ng a nd replication wher eas t he C-term inal proline-rich
activation doma i n necessary for transcript ion!lll
activation . The DNA binding domain haa the ch aracteristic
features necessary for dlmeriz!lltloh (Hermod at a1 . 19 8 9 ) .
The He La CCAAT-bi nding pro t e in CP1 ha s t wo he terolo gous
l'
subunits which can functionally complement the yeast
transcription factors HAP2/HAP3 complex and they recognise the
same DNA binding sequences . The proteins CPl, CP2 and NFl are
different factors. Each protein binds to its recognition
sequence with affinity that is three orders of magnitude
higher than the binding of the others . This indicates that
different CTF/NFl proteins have d ifferent DNA binding
specificities probably because of heteromer ization (Chodosh et
.,1. 1988&; Chodosh at ti l. 1988b; Mitchell a nd Tjian, 1989) .
CTF /NFl recognition sequences are the potential binding
sites for other proteins l i k e CCAATjenhancer binding protein
(C/EBP). The binding of C/EBP to the CTf/NFl motifs was found
to be involved in transcriptional activation (J one s et al.
1988) . McQuillan et ez , (1991) showed th,:,.t cells which do not
express NFl proteins can still stimulate transcription from
NFl binding sites be cause of the existence of funct ionally
distinct Nfl related proteins in different cells .
Nuclear factor 1 was shown to be important for cell
specific enhancer function of adipocytes (Graves et az . J.991).
The qlial cell-specific expression of the neurotropic JC virus
regulatory region was shown to be dependent on the NFl binding
sites (Kumar at al . 1993).
The proteins that bind the CCAAT motif need not be
transactivators since some of them may act as negative
regulators . An example of this is for the sperm histone H2B-l
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ge ne pr omot er of s ea urchin embr yos (Jones at a1. 1988) .
~ Role of Doact i vators and d ifferent TFIID comp l exu
for transcriptional a c tiva tioD:
studies usi ng the TFItD fraction confirmed that
additional f ac t or s known as coactlvators are necessary t o
bridge the t r ans act l va t or s SPI or Nfl with the general
transcrIptional machinery transcriptional a c t ivation (Pugh and
Tjlan, 19 9 0; Oynlac ht a t al . 199 1 ; Ta nese at a1 . 1991) .
Simi larly, coactivators i n ye ast were identified a nd termed a s
med iators or adaptors (Kelleher e t a l . 1990; Flanagna n et e z .
1991) . The c oa c t i va t ors f or NFl were pur l ! led f r om 'r FIID
c nmp l e x and found to mediate ac tivation by t h e chimer i c
g lutamine-rich act i vator , SPI (Pugh a nd Tjian, 1990 ; Dynlacht
et al . 1991) . The copu ri f i c a t i on of TBP and coa ctivators
suggested that part of the co a ctivator function i s c ontr i but ed
by different TAFs associated with TBP (Pugh and Tjian , 1990;
Dynlacht et al . 199 1). Coactlvator activity , for ex a mp:i.e,
up stream s t i mu l a t or y act i v ity (USA) , i s necessary fo r
transactivat ion by SPl and USF and this USA is not tightly
a ssociated wit.h TBP (Heisterernst at a1. 19 91 ) .
The huma n TAFn 250 o f TFI I D wa s cloned and f ound t o be
i d e nt i ca l to the cell cycle regulatory c cgl gene . Th i s
s uggests t hat TAFu 250 may be involved i n the activation of
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gene s tha t. control ce l l cycle progression (Ruppert at a z .
1993 ; Hi s atake et ea , 19 9 3 ).
Different TArs act as mediaters between TBP and
transact t va tors form.ing a single TFI ID complex called holo-
TFIID complex (Zho u at a1. 1992 ; Zh a u at a1. 19 93) . But Drou
at al. (1 99 3) reported that there are at least two distinct
TF IIO populations composed o f both common a nd u nique TAl's . It.
was shown t hat ch imeri c GAL4-TEFl activates transcription from
two different Tfl I D popu lations . One is unique to GAL4-TEFl
activation a nd the other one is common for transcriptional
stimulation by three d i f ferent activat.ors inc l uding GAL4-TEFl.
The existence of different TFIID complexes for different
transactlvators needs to be f ur t her i nv es t i g ated •
.!.4 PAPILLOHAVIR US ES :
Papillomaviruses are sma ll , no nenve lopecl., circular,
double s t ra nd ed DNA viruses of about 8kb in size . They belong
t o the subfamily papillomavir inae o f papovaviridae . In i t ia l
studies on c ot t ont a il r abbit papillomavirus (CRPV) and a rare
huma n disease , epidermodysplas ia verruciformis, Lnd I c at.ed that
pa p illomaviruses mi ght be import ant for the development of
epithelial neoplas ias . Subsequently a large body of
inf orma tion accumulated about the role of papil lomavirub.l":s i n
causing ben ign and malignant cancers . Bovine papillomavirus 1
(BPVl) i s the most extensively studied virus a nd it s er v ed as
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p rototype virus for understanding t he molecular studies of
papillomavlruses (Girl and Danos, 1986) .
Papillomaviruses a re highly species spec i f ic and i nduce
squamous epithelial tumours and fibroepithelial tumo urs i n
the i r natural hosts . It has not bee n possible to propagate
these v i r us e s in tissue c u l t ur e and t he mode of viral
repl ication i s not und e r s t ood precisely (Howley , 19 90) .
papLj.LcmavLruaeu are s trictly epltheliotropic in nat u r e
and infect the ba s al layers of t he epithelium . The vi ra l life
cy cle is complete on ly in the upper layers o f differentiating
kerat inocytes . All viral replication function.; are rest ricted
o nly to t erminally differentiated cells (HOWley, 199 0) . Th e
ge nomic organizat ion of BPV1 was f irst studied because the
viral DNA can be relat i vely easily obtained from a n i ma l
lesions . Subsequently, over 68 t ypes of h uman papLl.Lorae v Lr un ea
were isolated (Payne et aj , 1993) from different human l esions
and were characterised as i n f e c t i ou s agents of cutaneous , ora l
and anoqen i t a l l es i ons (de Vi lliers , 1989) .
Huma n papillomavirus es (HPVa) show s tri.ct
epitheliotropism like other papillomaviruses. Th ey are
involved i n the de velop ment of benign ad ult a nd juvenile
laryngeal papillomas and gen i tal cond y l omata a cumi na t a o r
genital warts . The benign lesions caused by the l ow r i sk HPVa
(example : HPV11 a nd HPV6) rare ly p r ogr e s s to malignancy . The
high risk viruses for example HP'116 a nd HPYl8 a re known t o be
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associated with the malig nant ge nital ca ncers especially
cervical ee r cfncne . Olf fe:r:'en t hu ma n papi llomaviruses
s poradically or regularly infect the genital t r act , h e nc e
s ometimes one or more HPVs can be obser ved i n the l e s ions (z ur
Ha usen, 1 9 89 ).
L.a.......A (I'l1oale organization ot' papl11omavirUlI811 :
DNA se q ue nc e c ompari s on o f diff eren t h uman
papillomaviruses led t o the establishmeilt of at least eight
early ge ne s (El -E8) a nd t wo l a t e ge nes (Ll and L2), a l t h oug h
minor vez-Lec icne do occur a mong d i f fe r en t fam ily members . All
the different ear ly a nd l a t e ge nes a re l oc ated on l y on one
strand g i v i ng r i s e to early an d late tra nslationa l open
readi ng f rames (ORFs) . Overall, t he genomi c organization is
conserved with respect to the size a nd l ocat i o n of op en
reading frames among d if f e r en t papil lomaviruses . The op en
readi ng frames E3 and E8 are not estab l ished i n HPVs as seen
in BPV1. Transcript i o n of p a p illoma vi rus es is complex because
of the presence of multiple promo ters , d ifferent spl i c e s ites
a nd differentia l s ynt h e s i s of mRNA species in differen t ce l ls .
Additiona l ope n r ead ing frames a r e also pr ese nt i n HPVs such
a s E5a a nd E5b i n HPVll (HOW ley, 1990; Gi r i a nd Danos , 1986 ;
Chiang at 81. 1991).
Papi llomavi r uses have an unt rans lated r e gu latory region
consisting of enhancer an d promoter elements between t he s t op
r s
co don o t: Ll ORF and first codon of E6 ORF. The regula tory
region is known as n onc od ing region (NCR) or upstream
regulatory region CURR) or l ong co ntrol region (LeR) . The size
o f the r egulator y region varies among different HPVs. The
enhancer and promoter e lements of the NCR respond to different
c e l lular and vlrally encoded pr o t e i ns. The J' extremity of NCR
is GT-rich in genital papil lomaviruses whereas it is AT-rich
in other viruses. This 3' end has a p o l y a d e nyla t i o n signal for
the late transcripts . Episomal replication a nd maintenanc e
sequences are also located at t h e same posi tion. The 5' e nd of
t h e NCR is conserved and conta ins repeats of the palindromic
sequence , ACCGN4CGGT, a characteristic of papillomaviruaes and
<:ypica l prom oter e lements (Giri and Danos, 1986) . Vira l E2
proteins i nteract with t his sequence (Howley, 1990 ) •
.L.a........2. Role of yiral a nd ceUular factors i n t h8
o ncogenicity of human pap illomaviruse,:
The malignant cancers associated with HPVa have
i ntegrated viral DNA a nd the majority of such tumours possess
v i r a l t r a ns c r i pt s of E6 a nd E7 ORFs. The E6 and E7 pr o t e i ns
are co nsidered as viral oncoproteins particularly in the case
of high risk HPVs and t hey are found to interact with cellular
f actors such as retinob lastoma pro tein (pRbl a nd p53 . Th e E6
pr ot e in binds and degrades t he tumour suppressor ge ne pr od uc t ,
2 0
pb L, ....h erea s t he E7 protein inte r acts wi th pRb . The precise
r egulat i on of cellular DNA rep l ication and mitoti c cycle by
E6-p53 a nd E7-pRb i nteractions is no t c l e a r l y defined . They
appear to play major roles b e c aus e s uch interactions are not
essent ia l fo r be ni gn proliferative l e s i ons caused by l ow r i s k
HPVa like HPV6 and HPVll (z ur Hausen , 1991 ) . These types of
viral a nd ce l lular interactions mig ht p lay a role i n the
instabil i ty and chr omosomal changes l e a d i ng to t he progr e s s i on
from the latency s tate to mal ignancy induced by high r i sk
HPVs. I n cases of malignancy by low riSk HPVa, mutational
events Bet by exogeno us factors s uch as s moking mi gh t p lay a
pivota l ro le (zur Hausen , 1991 ) .
The importance of chromosome 11 which harbours ne ithe r
p5 3 nor pRb ge nes was notably observed to p l ay an impo r tant
r o l e i n the r egUl at ion of HPV transcription (zu r Hau s en,
199 1) . Deletion of c hromosome 11 wa s f ound t o s uppress HPV
transcription in nontumori ge n i c cervica l ca rcinoma-fibrobl ast
hybrid segregants wher e as los s o f ch r omosome 11 did not affect
HPV t r an s c ript i on i n tumorigenic segregants (zur Hausen ,
1991 ) . The SV40 sma ll t-like factor Le., P R5 511, t he
regUlatory subunit of prote i n pho sphatase 2A (PP2A) • was f ound
to t ransactivate HPV gen e transcription in t he c hromosome 11
deleted fibroblas t s (Smits et az , 1992 ) .
The observations made by swift e t e .l , (1987 ) suggested
t hat a ne uroblastoma cell line supported e nha nce r f unct ion of
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HPVla . The HPV1 6 DNA has been observed in t h e plas ma cell
tumour o t: cerv ix. This raised an i nte r e s t ing q uestion whether
HPVa can a lso i nfect cells o f lymph o i d origin. It i s not kno wn
whether the pla sma cell ma lign ancy ob s er ved i n the above case
was a seque l to the prima r y i nfection of ep ithe lia ! cells by
HPV16 (Pay ne a t a1. 199 3 ). Re c e ntly, Ar be i t at al. ( 1993)
observed the expression of E5 mRNA a nd E7 oncoprotei n in
neur oep i the l i a l tumours of t r an s ge n ic mice . These different
observations s uggest t hat Ubiquitous and cell -specific ho s t
f actors mi g h t be r e spon s i ble for the transcriptio n of HPV
gen e s . The identification o f tissue -specific enh ancers a nd
the i r cognate tran scr i p t i on factors h a s s hed some ligh t on t he
importanc e of epit helia l cell-specific a nd Ubiqui tous
tran s cript ion f actors in the t ranscript ional regula tion of HPV
vi ra l gene expr ession in e p i thelia l t i s s ue s .
.L..a....J. lfopcodbq regions of human papillomayiruII88~l
~ Trapscriptional regulation by HPVU enhancer
elements :
Th e no ncod i ng r e g i on (NCR) of HPVl6 is l ocated be t we e n
the 3' end o f Ll ORF an d 5' end of £6 ORF (n uc l e o tide 7150-
82 ) . The NCR contro ls the vira l gene expression f r o m p97
promoter :Seedor f at al . 1985; Glos s at a .l , 1987) . The NCR of
HPV16 c o n t ai ns i nd uci ble a nd ce ll-spe cific e nha ncer e lements
(F ig . 1). Three vi ra l E2-bind ing motifs a c t ing as i nducible
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enhancer s we re ident i f l ed upstream of the p97 promoter wh i ch
r e sponds t o t he t ransact i vat i on an d repres s ion by the vi r a l E2
pro t eins (Sou s a at al. 199 0 ; Phel ps a nd Howle y , 19 87 ; c r i pe e t
a l . 19 8 7 ) . An e p ithelial cell - specific enhancer of 4 00 base
p a irs (nucleot i d e 7 4 54 - 7 85 4) was identified in HeLa ( HPV18
integrated cell lin e) ce lls . This enhancer is l oc ated upstream
of t he two prom oter-prox ima l E2-binding motifs . Hence thi s
e nh a n c e r is als o t. ez-a ed t o b e an E 2-ind ependent en h a n c e r
(Chong st al . 1991 ) . The ce ll - s pecifi c enhancer also consists
of a g l uc oc orticoid or prog e s terone r e sponsive e l eme nt (GRE or
PRE) ( nuc l eotid e 7 6 4 0 - 7 654 ). The GRE was fo u n d to be essential
fo r glucocorticoid-dep en dent oncogenic transformation of baby
r a t k idney epithelial c e lls (Pa t e r e t: al. 19 88; Ch an et al.
1989 ) .
The e p i t he lial cell-specific enhancer of 400 base pa irs
has r ecognition seque nc es f or transcription factors su ch as
NFl , TEFl, TEF2 , cee-.i , AP1 and un identified factor , for
examp l e , nuclear f act or 1-associated factor (NFA) (Chong et
al. 199 0 ; Cho ng et al. 1991; I shiji et a1. 1992; Taniguchi et
er . 1993) . The c omp l e x array of overlapping recognition
s eq ue nces for t rans c r i p t ion fa ctors i n c l ude 7 NFl sites, 3 APl
s t t e s , a TEF2 b inding site overlapping with two TEFl sites .
One o f t he NF l s ites partially overlaps wi t h one of the TEFl
binding s i tes. A 37 base pair fragment (nuc l e otid e 7 683- 77 19)
of t he 400 base pa ir enhancer region was obser ved to be active
Fig . 1 . Schematic representation of different enhancer elements
of HPV16 noncoding region a nd the interacting transcription
factors .
CE: Th is term i s used for the purpose o f this i llu s tra t ion.
This represents the epithel ial c e l l - s pe ci f ic enhancer elements
( nu cleotide 75 24-7 62 1 and 7 62 9-7 71 9 ) (Chong at al . 1991). KO:
This term is used for the purpose of this i llu s tration . Thi s
represents TEFl and i ts coactivator-mediated keratinocyte
dependent enhancer (Ishiji at al . 1992) . CTRE: Cell-type
dependent regUlatory element identified with HPV-associ ated
epithelial cell lines (Ta niguchi et al. 199 3). EGFRE:
Epidermal growth f a c t or r e s pons i ve element ('iasumoto at a1 .
1991; Taniguchi et ez . 199 3) MCE: Mi n i ma l constitutive
enhancer (Marshall et ar , 1989) used in this study .
E2: Viral E2 protein ; NF IL-6 : Nuc lear factor f or
Interleukin-6; GRE: Glucocorticoid responsive element ;
NFA: unidenti f ied factor called nuclear factor I - a ssoc i a t ed
factor; a and b : unknown factor interactions.
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and found to interact with t ....o TEfl pro t e i ns t hat r eq u i r e a
I bit inq c oa c t l va t or i n ke r a t i nocy t e s (Ish l j i e t e z . 1 9 9 2 ) .
The t wo f r aglllen ts with nucleot i d es f r oll 752 4-762 1 a nd. 7629 ·
711 9 (9 1bp) ha v i ng' potentia l b ind i ng sit es fo r Nfl were a l s o
f ound to be e e e rve in e pi t..,el ia l c ella but not i n fi b roblas t s .
The NFl s pe c ies tha t a r e respons ible f o r t he expr es s ion froll
the s e fragments ac t i n an epithelial cell - specif ic fashion
(Apt et a1. 19 93 ) .
Another inducible e nha ncer kn own a s ep iderma l g rowth
fact o r r espon s i ve element (ECFRE) was t entat i vel y mappe d
be t ween 7643 a nd 77 67 bas e pa i r s . Thi s ele ment wa s ob s e r ved t o
downre gulate t h e e x p r essio n ot' £ 6 / £7 mRNA ( Ya sumoto at e r ,
199 1 ; Tan Ig u c h i a t e j , 1993 ) . The e nhanc er e leme nt fro ll 74 54-
7 ti32 base pa i rs was i de ntified a s c e ll - t ype dependent
r egul atory e l e . ent (CTRE) i n HPV-as s oci a t ed ep i thelial c e ll
l ines but not i n HPV- f r ee ep i thelial cell lines . The CTRE has
t hree NFl binding sites . Mut at ional ana l ys i s i nd i ca t es that
a l l three NFl s ites s y ne r g i s tic a l ly ac t iva te transcript ion r ee
cOllp lete activity of t he CTRE (Tan i guc h i e t a l. 1993) . The
nuc lea r fa ctor res po n s i bl e for inter l euk in expression (NF- IL6)
r epress es HPV16 NCR by bindi ng to the s eque nc e s f rom 14 54-7 7 6 6
base pairs . This suggests t he role o r NY-IL6 as the host' s
defence mech anism to c ount e r a c t the viral infection (Kyo a t
.Ill . 19 93 ) .
Prev iously Ma r s ha ll et e f , ( 1989) i d e ntifi e d t he
2.
sequ e n c es f rom n u cleoti d e 7224 -7778 in t h e NCR of HPV16 a s the
minima l constitut ive enhance r r equ i r e d for cell-specific
ex pression. This was us ed in the prelimi na ry e xp e r i ments o f
this study . It was p roposed that the ep i t he lial c e ll
specificity is brought about by t h e coope rative i nt eraction of
d i f f e r ent ub i qu itous a n d ce l l -specific t r a ns c r i pti on factors
binding to t hei r cognate binding s ites ( Chong et al. 1 9 91 ).
The NFl bindi ng s ites a n d a s ubset of NF l. prote ins were s hown
to pll!lly a major rol e in t h e epit helial cell-specific
ex pression of HPV 1 6 and pro ba bly other genita l papilloma v i r a l
genes (Apt at a l . 1993) .
TrllDsactivatioD aDd reprenioD by enhance1'
elelllent. of BPV18 :
The noncod i ng region of HPVIB is 828 ba s e pa i r s in length
(nuc leotide 7134 -105) ex tending be tween t he stop codon o f Ll
ORF and t he first cod o n of E6 ORF. The NCR of HPV18 h a s a
typica l TATA bo x an d transcription s tarts f r om p l05 promoter .
The NCR has a CCAAT box -like seq ue nc e (CAAT) upstream of the
TATA box as seen in HPV 11 and HPV16 (Co le a nd Danos , 1987 i
Thierry at e.t . 1987 i Bernard at ai . 198 9 ). Based upon t he
response t o virally e ncoded pr'::lt e ins , othe r s timUli an d
ce l lular factors , t he en hancer e lements can be c lassified into
i nduci b l e , co ns titutive a nd cell-specific enhancer e lements
(Fig . 2) . Four co pies of E2-responsive seq u e nces are pr ese n t i n
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the NCR of HPV18 . Two of these sites are situated between TATA
. a nd CCAAT boxes and repress the promoter activity in
keratinocytes in the presence of BPVl E2 or HFV18 E2 proteins .
These sites activate transcription of heterologous promoters
by the E2 proteins when present distant f r om the promoter
(Pernard at a1 . 1989) .
The s e c ond inducible enhancer is viral E6-dependent
enhancer (lE6 ) located 500 base pairs ups t r e a m of the E6 c a p
site (Gius at e j • 1988). A 30 base pair region designated as
IETPA is responsible for phorbol e s t e r activation of HPV18
gene Qxpress ion fr011l a heter ologous promoter (Gius and
Laimins, 1989). Anotrer inducible e nha nc e r Le.,
glucocort icoid or progesterone responsive element (CRE/P RE)
(nu c l e ot i d e 7839-7853) responds to glucocorticoids or
progesterone and med iates transcriptional act ivation (Chan at
0511 . 1989). The minimal constitutive enhancer (MCE) is a 230
base pair fragment (nucleotide 7508 - 773 8) and is active only
in certain cervical carcinoma cell lines, a neuroblastoma cell
line and some f ibroblast cell lines (Swift a t 0511 . 198 7 ; Giu s
at 0511 . 1988; Marshall at 0511 . 1989) .
The transcript ion factor Oct-1 is known to repress
transcription from a 138 base pair fragment of NCR. The oee -.r
does not repress heterologous promoters , but r'e pr eeee e HPV18
enhancer. Its action is through protein-protein contacts
(Hoppe- Seyler at 051 1. 1991) . .\. novel octamer binding prote in of
Pi9. 2. Diagramatic representation of constit utive and
inducible elements of HPV1B and DNA-protein interactions.
IE 6 : Induc ible e nhancer for v i ral E6 proteil (Gius at e j .
1988) . I ETPA: I nduc i b l e e nha ncer f or tetra decanoylphorbol
ace t a t e (Giu s a nd Lai mi ns , 1989) .
MCE : Minimal co ns t itut i ve en hancer (Mar s h a l l at al.
198 9 ) . CRE: Gl u c oc or t i c o i d responsive e lement; E2 -RS : Viral £2
respons ive s equ enc es; KRF: Kera tinocyte-specific t r ansc r i pt i on
factor ; Oct-l is s hown as lack of DNA b i nd i ng (Ho p pe-sey l e r at
81. 1991) .
RsaI : restriction s ite for Rsar.








92 kd was identified and shown to activate HPVla transcription
in cell-cycle dependent manner (Royer et al. 1991).
A negative regulatory domain of 23 base pairs in length
was identified upstream to CCAAT-box like sequence . It is
known to bind Y'il repressor and found to repress the HPVla
pl05 promoter activity in HeLa cells. This suggests that the
distal API binding site cannot activate pl05 promoter due to
the binding of the repressor to the negative regulatory
element. This repression mechanism was suggested to be
important in order to downregulate the activity of HPVla NCR
in premalignant latent stage (Bauknecht et al. 1992) .
Mac k and Laimins (1991) identified a keratinocyte
specific transcriptional activator- I (KRF-I) . It ....as found to
be necessary for the synergistic activation ....ith API from the
constitutive enhancer. The two API binding sites were shown to
be important for JunB dependent activation of the pl05
promoter in epithelial cell lines. Ho....ever, it was suggested
that other transcription factors may cooperate with API in the
t issue-specif i::: expresssion of HPVla (Thierry et al . 1992) .
The role of NFl binding sites in the expression of HPVl8
enhancer is not well established, although putative motifs for
NFl are present.
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.L..i..d Human p.pillomay iruL....ll ( BPVU) '
The DNAof h uman papillomavirus 11 (HPVll) was identified
in the benign l aryngea l pap illoma and was sUbsequently
characterised (Gissmann et er . 1982 ; rdrtmann et az . 1986) .
HPVll is mostly f ound i n episomal form and is rare ly
associa ted with malignant l e s i o ns. It causes benign lesions of
the respira tory tract including especia lly, t he l a r yn x . The
benign lesions caused by HPVI l i n external ge nitalia are
called condy loma ta acuminata. HP1Jl1 i s also associated with
pr en e op l asti c cervical l e s i ons and cervica l ca rc inomas
(Glasmann at al. 1983; Stoler at al. 198 9 ; Sherma n at al .
1992) . HPVI1 was found in papi llomas of bo th juveni les and
adults a nd i n rare conditions i t was found to be associa ted
with s quamous ce ll carc inoma s (sec) of lung and skin (Gi s s man n
et a1. 1983 ; Byr ne a t 41. 1987 ; Cohen et aj , 19 92 ; Shah and
Howley , 199 0 ; Tsu t sumi et a1. 1989).
HPV11, unlik e t he other benign virus HPV6, is freq ue nt ly
present i n respiratory pa p i l loma s espec ially in infants. The
trans mission of v i rus from mothers to infants i s postUlated to
occur through b irt h ca na l. Juvenile-onset patients with
l a r yn g eal papillomas might acquire t he virus 1n utero probably
because of the infected birt h cana l but this mode of
trans mission is no t frequent (Shah and Howley, 1990) .
HPV11 like other papillomaviruses is s trict ly
epitheliotropic , but t he s ites of infection an d thO! degree of
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oncogenicity by HPVll vary among the on coge nic types s uch as
HPV 16 and HPV18 (Howl e y, 199 0 ) . Stoler at al. ( 19 90) were able
t o induc e ex perimenta l con dy lomata by HPVl 1 i n nude mice . The
l e sion s were i ndist i nguishable from natura l ly occuring
condy lomata ac um:lnata . Recently, 1n vivo a nd in vitro assembly
of r e c ombi nan t virus-like part i c l e s (VLPs) expressing Ll co a t
pr o te i n but not L2 was demons t rated using baculovirus system
(Rose at al. 1993) . Still, there i s no f e a s i ble s yst em t o
propa gate t his virus i n l arge qu ant ities .
~ Role of genomic alterations in t.l.18 on coge D.!!L
potential of BPUI:
In a rare case of c h r onic l aryn gotra cheobron ch i al
pap i l lomatosis a nd metast atic s qua mou s cel l carcinoma of lung,
the noncod i ng region (NCR) of HPVll was f ound duplicated a nd
believed t o ac t as mutage n t o bring about chromosomal
i nstabil ity (Byrne et al. 19 87 ) .
There a re significant variations i n the E7 proteins of
HPVl l a nd HPVI 6 . In-frame inser tion of 124 base pa irs f rom the
5' a mino end of the c oding s eque nce o f HPV16 E7 ORF i n to t he
5' end of t he E7 coding s e qu e nce o f HPVll r e ndered HPVl l
genome t rans f o rmati on competent in the pre s en c e of r a s
onc o g e ne (Pater e t al. 199 2 ) . A un i qu e varia nt of HPVll
( HPVllvc) isolated f rom ve rrucous carcinoma o f male genita l
organs was found t o t ransform neonata l rat k i dney epit helia l
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cells i n the presence of xa- r e e oncogene with comparable
efficiency to that o f HPV16 DNA. This HPV11vc isolate was
shown to transform fibrob lasts e ve n in the absence of rae
oncogene . This var i a nt of HPVl 1 was found to c o nt a i n 16
nucleotide changes in the noncoding region and EI , £2 , E4 a nd
E5 ORFs . Th is i ndic a t e s that in vivo mutations of t he viral
genome might alt er t h e oncogenic potentia l of HPVll (McCle nnen
at az. 1992 ) •
.L..L.L..l ~ODal requlat ion b y enhanc er e l ements ot.
The genome of HPVll isolated from laryngeal papilloma
cons ist s of 7 9 3 1 base pa irs e nc oding E1, E2, E4, ESa , E5b, £6
a nd E7 early proteins and Ll and L2 late proteins . The r egio n
between Ll ORF and E6 ORF i s the no ncoding reg i on consist i ng
of different e nhancer e lements that regulat e the v i ra l gene
expression (Dartmann a t a1 . 1986 ) . The different open readi ng
frames and their possible functions are shown i n f i gure 3 .
Th e noncoding region of HPVIl starts within the Ll ORF
and extends up to the first codon of E6 ORF. The NCR has a
typ i cal TATA bo x located at the nucleotide position 66 . The
CCAAT box has the sequence CAATCT simila r t o the CCAAT box-
like sequence of HPV16 a nd HPV18 (Dartmann at a1. 1986) . The
NCR has three constitutive en hancer e lements namely CEI , CEIl
and CEllI . The inducible e lements are E2-responsive sequences
Fig .3 . Li nea r ized map o f HPVl l.
coding r eg ion s of different open reading f r ame s (ORFS)
i ndica ted as open bo xes. The pos s i ble function of t he





( E2- RS) and the glucocor ticoid responsive e lement (GRE)
(Fi g . 4) . The term constitut ive enhancer was used s i mp l y based
upon t he di fferential expression o f the e leme nt s in different
c e ll t ypes . Th e enhancer element , CEIII ( n ucleotide 7224-7493)
is a ctive i n different e pithelial and f i br obl a s t ce l ls
( St e i nbe r g at a1. 1 98 9 ; Auborn et 81. 1989; Auborn and
Steinbe rg, 199 1) .
The co ns ti tut i ve e nhancer e lement eEII (n uc leotide 767 7-
77 47 ) was found to be active in the cervical carcinoma cel l
lines C3 3A ( HPV free) a nd ReLa (HPVl 8 i ntegrated) an d is
relative ly inactive in the monkey k idney e pithelial c e l l line,
CV- l (Chi n at 811. 1989) . The constitutive e nh a n c e r eEl
(n'.lcleotide 7769-7831) was show n to be act ive i n CV-1 a nd
prima ry keratinocytes but n o t i n He La o r C33A (Hi rochika a t
aL 1988 ; Chin et 091. 1988 ; Dolla rd et a l. 1993) .
Recent ly, Dollard at 091. (1993) ident ified a 45 base pa i r
region ( nucleotide 777 7-7831) whi ch is ....ctive i n a
kerat inocyte-dependent mann e r . T he mi nim a l constitutive
enha ncer (MCE) , c onsisting o f 213 base pairs ( nuc leotide 765 7-
78 70) , inc l udes CEI and CEIL The MCE u s e d in t h i s s tudy i s
required for e pithelial cell-specific f unction (Marshall at
af . 198 9 ) . The sequence s of Me E are devoid of E2-re s ponsive
s e q ue nc e s . The mini mal constitutive e nhancer has rec o gn ition
s equences for tranE'cription factors CTF!NF1 , API, C!EBP, NFA
and homologous GT, Sp h and P motifs (Hi r o c h i k a at 091 . 198 8 ;
Piq . .... Constitutive , inducible a nd cell-specif i c enhancer
elements of HPVl1 .
CEI , CEIl and CEIII : Constitutive enhancer elements a s
described previously (Ch in at a1. 1989; Hi rochika at 81. 1 9~ 8;
Dollard at ef , 19 9 3; AUbo~n et a1. 1989; s tein berg et a1.
1989 ) . KD: The t e rm i s used f or the purpos e o f t his
illustration and represents the keratinocy te-spec if i c
enh ancer (Dollard at al . 199 3) . MCE: Minimal con stitutive
en ha n c e r (Ma r sha l l at al .1989) f or epithelial cell - s pe cific
expression u s ed in this s t Udy . GRE: Glu coc ort i coid resp ons ive
element; E2-RS : E2- r esp o ns i ve s equences .
The different nucleotide positions a re n ot to s cale .
Arrow indicates the transcription start site £6 promoter.
,B
Dollard et a1. 1993).
The enhancer CEII was shown to bind CEIl-binding
proteins which are transcriptionally inactive in primary
keratinocytes and active in C33A (Dollard at ej • 1993; Chin at
al. 1989) . The CEIl has recognition sequences for NFl and
putative binding motifs for API. The enhancer , CEI has several
overlapping binding motifs for transcription factors such as
C!EBP, NFl and NFl-associated factor (NFA) (Dollard at a1.
1993). The nature of proteins that bind to these sequences of
CEI and CEI! is still unclear .
The inducible element GRE is located (nucleotide 7817-
7832) within the minimal constitutive enhancer and responds to
both dexamethasone and progesterone (Pater et al . 1988; Chan
et al. 1989).
The E2 proteins of HPV11 act as transcriptional
regUlatory factors and modulate viral gene expression from
the E6 promoter by binding to the inducible elements Le., E2-
responsive sequences (E2-RS). The full length E2 protein has
an amino terminal transactivation domain and carboxy terminal
DNA-binding domain. Two other E2 viral proteins , E2-C and
EIM"E2C are known to act as transcriptional repressors (Chin
et al. 1988; Chiang et a1. 1991). The full length E2 protein
activates HPV11 E6 promoter in C33A (Chin at a1. 1988) .
The full length E2 protein can also repress the E6
pr':.lIlloter function when either CEI or CEIl is delotQd from cbe
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NCR. But Dlul t i lne r i z a t i on of either car or CEIl in t andem
overcomes the r epre s s i o n caused by the E2 protein in C33A
cells (Chi n et a l. 19 89 ) . The E2 protein is a strong repressor
of CEIl and car i n primary ke ratinocytes. But the cellu lar
factors binding t o CEIl are functiona lly i nactive in primary
keratinocytes . Hence it has been proposed t ha t E2 r epr e s s ion
i s abr09ated when CEI l proteins or their c oa c t i v a t o r s may be
act ivated or available duri ng t he pr oce s s of differentiation
or n e o p l a s t i c ccnver-s I cn ( Dol18rd e t e .z , 1993) .
The full length E2 p rote in was found to b e responsible
for positive regulation of vira l replication . '.i.'he r epr e s s i ng
E2 proteins did not support r ep lic at i o n in vi tro (Chiang et
al . 1992).
l.......1. Rol_ of retinoids :
Re t inoids are physiological r egUl a t o r s of growth and
differentiatio... of a number of epit he lial tissues . The
retinoids such as retinol (vitamin A) and its metab o lic
der i vative retinoic a c i d important f or no rma l
embryogenesis (Glass and Rosenfeld , 1991 ) . Retinoic acid not
only acts as a morphogen but i s essential t o maintain the
norma l i nt egr i t y of the epithelial tissues (de Lu ca , 1991 ) .
The i n vi vo experiments using vitami n A deficient mice
i nd I c at e d that the extensive keratinization may be a
c o ns eque nc e of lack of phys i o l og i cal concentrations of
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retinolds in the e pithelial t i s s ue s . This confirms the r o l e of
ret ino i ds i n kerati n ge ne expression (de Luca , 1991) . Some o f
the studies indicated t hat at phar maco l og i ca l doses , the
r eti no i ds inhibi t t umo r i g ene s i s (de Luea, 19 91 ) . The retinoids
e xe rt t he i r ac tions t hrough different types o f nuc lear
receptors na me l y r e t ino i c acid receptors (RAR) - RARa, RARP,
RAR'Y a nd ret inoid x receptor.:: (RXR) (d e Luea , 1991;
Anesk ievich and Fu chs , 1 9 9 2 ) .
Various nuc lea r receptors for retinoic acid control the
expression of different cellular genes by b i nd i ng to the
r etinoic acid responsive element (RARE) or RXR element (RXRE)
located i n t he cellular g e nes . Recent studies have shown that
nu c lear receptor trans l o c a t i ons gave rise to the concept that
rf~t1noids a nd t he il: receptors might be i nv o l ved i n neoplasia
(de Lu ca , 1991 ) .
..L..L.1, Pig mouse embr yonal cllrc inom..A...£.l.ll.u.
The ce l ls of P19 mouse embryonal carcino ma cell line lire
pluripo tent in natur e and can differentiate in cell c ul t ure
into neurona l and muscle cell types whe n they are treated with
retinoic acid (RA) a nd dimethylsulfoxide (DHSO), respectively
(RUdnicki and McBurne y, 1987 ) . Differen t isoforms for the
nuclear r ec e p t o r s -RARa , RARtJ a nd RAR'Y were identified i n P19
EC ce l ls. Th e different isoforms can be seen in different
l e vels either in RA-d!f ferentia ted cells or un!nduced P19
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cells (Leroy et al. 1991 ; Zelent ec al. 199 1 ; Kastner at az ,
1990) •
The members of the gene fami ly, API , a re ex pressed
differentially in PIg EC cells . The c-jun pro du ct i s expressed
at high levels in RA-differentlated cells whe r e as juna is
expressed nei ther in undif fe rentiated nor i n RA-differ e ntiated
cells. JunD expression r e ma i n s t h e same i rrespective of
differentiation status (de Groot at ef . 1990a) . Ectopic
expression of c -jun in the undifferentiated cells leads to
d i f f e r en t i a t i on and r e s e mble s the RA-differentlated
derivatives both morphologically and biochemically. I t was
s uggested that t he effects of t he c -jun produ c t on RAR.8 g e ne
transcription might be r e s pon s i ble for c -jun dep end e nt-
differentiation (de Groot at al . 199 0b).
Two other t rans cripti on factors namely oe e -a an d Oct-4
are found at different levels i n un d ifferentiated (UD) and RA-
differentia ted s tates o f P19 cells . cec-a is e spc-eeaed only in
un cells a nd its expression disappears in RA- d!fferentiated
ce l ls . I n con trast, Oct-4 was found t o be induced by RA
differentiation . Two c is-elements wer e identified i n the
transcriptional co ntrol region of cec-a gene na me l y RARE lA
and RARE 18 which s howed no binding of nuclear r e cepecra . Ea c h
of t he two cis-elements wer e r ecogn i s ed by d i s t i nct cel lular
factors a nd t heir r ole i n RA- differe ntiation i s yet t o be
elucidated. Howeve r, i t was documen t ed tha t RARE l A and RARE
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18 are r e sp ons ibl e fo r the RA-med iated repression of Oct-3 i n
P I9 cells (Ok amoto et al. 19 9 0 ; Okazawa at al. 199 1) •
.L....i stat...nt of t he res e a r c h probl8Dl :
The in i t ia l objective of the s t udy wa s to determine
whethe r o r not t he minimal c onstitutive en ha ncer elements of
HPVll , HPV1 6 a n d HPV18 descr ibed i n 1.2, ",-" leh are required
for e p i t he lial - s p e c if i c function , active i n
undifferentiated a nd retinoic acid-differentiated PI9 mouse
embryonal carcinoma cells .
~:
PI9 EC cells were u s e d i n this stUd y i n order t o
investigate whether HPV enhancers a r e active, like t he membe r s
o f the othe r su bfamily , polyomavirlna e of sepovevt r tcee
(Nakahatri , 19 9 0 ) a nd whe t h e r similar type of cellu l ar factors
were i nvo lved . Retinoic ac id wa s chosen to differentiate P19
Ee cells t o s t Udy whether the d i f f e rent i a t ed cells can su pport
the ac tivit y of HPV e nhancers or no t s ince ret i noic acid is
k now n to be a modu lator of cellular t ranscript iona l mac hinery
(see 1. 3 .1) .
The minim al co nsti tutive e nhancer of HPV11 was chose n as
the model system for further s t ud i e s wi t h undifferentiated and
RA-differentiated states of P19 mouse Ee cells .
The s ubseque nt objectives o f the stUdy we r e :
1. To find out the i n t e raction o f ce llula r fac tors with
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the minimal co ns ti t utive enhancer (HeEl of HPVll an d to
f urt her correlate the i n vi t ro DNA- pr ot ein interactions with
i n v i vo activi ty .
2 . To f u r t her delinea te the minimal sequences of HPVll
MCE necessary f or t h e 1n vivo a c itlvity i n PIg Fe cells.
3 . To ch aracter ize the ce llu l a r factor i nt e r a c tion with
some of the ident i f ied min ima l s eque nc es of MCE o f HPVl l that
s how s ubst a n t ial in v i vo act i vity .
CHAPTER 2
MATERIALS AND METHODS
Restriction endonucleases and their l OX Rea ct buffers
were purchased from Gibeo-BRL. T4 DNA ligase and its 5X
premix, mungbean nue rease , exonuclease III and calf intestinal
phosphatase were also obtained from Gibeo-BRL. Buffers (IX)
for mungbean nu clease and exonuclease II I were prepared
according to the manual of Current Protocols in Molecular
Biology (Wiley Interscience). Reverse transcriptase was
obtained from Life Sciences. DNase! and Acetyl coenzyme A
(sodium salt) were purchased from Sigma .
acJ1P ) d CTP and e lS]dATP were from Amersham. NIck co tuens
and poly (dr-de) double stranded sodium salt were purchased
from Pharmacia . Thin Layer Chromatography (TLC) p lates and x-
ray films were supplied by Kodak. Retinoic acid (RA) was
purchased from Sigma .
Alpha-HEM medium (o-MEM) and fetal calf serum (FeS) were
supplied by Flow Laborator ies Inc. Gibco-BRL supplied trypsin-
EDTA. The Pl9 EC cell line maintained in the laboratory was
kindly provided by H.Hamada. Omnifluor was purchased from New
England Nuclear (HEN) .
The dideoxy sequencing kit (Sequenase kit) was purchased
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from united States Biochemical (US B) cci ccreefen , Cleveland,
Ohio . 5-B romodeoxyurldine wae obtained from sigma . Synthetic
ol igonuc leotides were pur ch a s ed from the Regional DNA
synthesis Labo ra tory , university of calgary .
The recombinant p lasmids , pSV2CAT a nd pAI OCAT maintained
i n the laboratory were provided by B . Howard . The HPV
enhancer-CAT plasmid constructs pT l , pTJ a nd p're i. ....e re as
described by Marshall et al . (1989 ) . The plasmi d, HPVll
en hancer in pUC19 WillS provided by H. Nakshat ri .
L1. Recombinant plasmid co ns t ruct s :
The negative con trol p lasmid, pAIOCAT , was as described
by Laimins et a L, (1982). I t was c ons t ruc ted by j oining t h e
Sp hI /BamHI fragment of pALO der ived f r o m pBR3 2 :<: wi t h the
Sp hI/BamHI fragment of pSV2CAT so that it be comes a cont rol
p lasmid having 2 1 base pa ir repeats an d TATA b ox of SV40
upstream of t he Ch loramphenicol Acetyl transferase (CAT) ge ne
coding seq uences , but l a ck s SV40 e nha ncer sequences . The
plasmid, pAIOCAT has a Bgl II s ite immediately up stre am o f the
21 base pair r e pe a t s .
The p os i t i ve contro l p lasmid , pSV2CAT, was as described
by Gorman et a1. ( 1982 ) . I t ser ves as a p os itive c ontrol in
the tra ns f e c t i on assays since it h a s SV40 enha ncer sequences
which are absent in t he negative c ontrol p lasmid pAI 0CAT.
The huma n papilloma v i r u s e nhancer-CAT construct s pTl , p T3
Piq.5. Phys ical map of the reco mbinant HPVll e nha ncer-CAT
p lasmid co ns t r uct, pTl.
The dashed l i ne s of the p l a s mi d i ndic a t e the location
of minima l c onstitutive e nhan ce r (HeE) se que nce s of HPVl l in
the pla s mid . The co nstitut ive e nha ncers of HPV16 a nd HPVl a are
p r e s ent in a sim ilar position i n the o ther t wo plasmid
constructs, pT3 and pTa! , r e s pec t i vely whi c h were us ed in the
preliminary studies. Del etion e nhancer de r i vat i ve s were a l s o
c loned a t the same site to ma ke de let ion mutant -C AT
co nstructs , pKSl , pKS2 and pKSJ.
CAT ge ne : Chloramphe nicol a cetyl t ransferase ge ne .
Ori : origin of r eplicat i on.
AmpR: Ampicillin r es i s t an ce ge ne.
'"
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a nd pT81 were as described by Ha r s h a l l at a1. (198 9) . The
p lasmid , pTl is about 4 . 4kb HPVl1 e nhancer-CAT c ons t r uc t
generated t o ha ve the 213 base pairs NdeI-Saur fragmen t
(nucleotide 7657-78 70) of HPVll noncod ing region (Oa rtma nn at
al. 1986) in the BglII slte of pAI OCAT (F ig. S) . The HPV16
enhancer-CAT construct , pTJ has a 554 b a s e pair Ss p I - Hp h I
fragment (nuc leotide 7 2 24 - 7778) of HPV16 noncoding reg ion
cloned upstream of the 21 ba se pair r ep eat s and TATA box of
pAI OCAT. The HPVla enhancer-CAT c onstr uct , pTa1 has the 23 0
base pair fragment (nucleotide 7 508-7 738 ) of IIPV1 8 noncoding
region c loned in the BglI I site of pAIOCA T .
L.1..Ll c o n s t r uc tion or delet ion mutant pla s mi d s :
The minimal constitutive enhancer sequences of the
noncoding region of HPVll (nucleotide 1 651 -187 0 ) c l o ned int o
the XbaI site of pUC19 plasmid ( Na ks ha t r i , 199 0) . The
de letions i n the HPV11 MCE were generated a s described
previ ously (Henikoff, 1 987) . Th e HPVll MCE cloned i n pUC19
p lasmid was linearized by BamHI and l<pnI to generate 5 ' and 3 '
ov erhangs, respectively . Exon uclea se III was used for mak ing
deletions as it does not attack a a-beee 3' ove r hang obtained
after KpnI digestion . At t he s a me time e xo nu c l ease III d i g e s t s
t he nu cle ot i d es uniformly from the othe r acce ssible 3' end
obtained due to BamHI diges tion . Afte r exonuclease III
digestion, mungbea n nuclease was preferred over 51 nuc l e a s e to
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c leave t he s Ln q Le s tranded ov erh a ng s s i nc e mung bean nuc lease
does no t a ttack a ny o f the base- paired n ucleot ld e s .
The l i nlila r i zed DNA was susp e nded in I X exonuclease I II
REac t buffer (50mM rere .ct , pH 7.5, 5mM MgC12 and 5mM OTT ) i n
50 III react ion volume a nd inc ub ate d a t 25°C a fter t he ad dit ion
of 3 uni ts of e xonuclease 11 1/1"'9 of DNA. At regular t i me
interva ls , a llquots of d i g es t ed DNA wer e t aken out and
incubated at 7 0 ° C fo r 10 minut e s . Af t er heat ina c t i vati on, IX
mungL ea n REact bu f f e r was a dded t o each a liq uo t i n a 2 Spl
r-eacr Ion vo l ume . Mu ngb ea n nuc l ease wa s d iluted wi th IX
mung bean nuclease REact buffer ( 30mM sodium ac etate, pH 5 ,
SOmH NaCl a nd I mM zinc chloride) and 2 units o f the di luted
mungbean nuclease was added to each a l iquot . The aliquots we r e
i ncubated at 37 °C for 20 min utes a nd t he rea c t i on was stopped
by adding l~l of O. 5H EDTA. The line ario:ed exonuc l ease I II
digested DNA was recircular ized by i ncul-:!ting ov e r night a t
l6°C after t he ad dition of 15~1 l i gat i on premi x and 1 un it of
T4 DNA. ligase .
The e xtent of d i gestion by exonuclease II I was determi n ed
by dideoxy seque ncing (sanger at al . 19 77 ) of the dele tion
derivatives of HPVl l HCE cloned in pUC19 pla smid. Th e
fragme nts from nucleotide 7785-7870 and 78 11-7870 of HPVl l MCE
sequences de r ived af ter exonuc lease III digestion were used to
make de letion mutant-CA.T co nstructs, pKSI an d pKS2. Th e vect or
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used to make deletion mutants was trhe linearized pAIOCAT from
which 1 . 7 kb AccI-BglII fr~gment was r emoved s i nce the wild
type HPV 11 MeE- CAT construct, pTl , do es not contain this
fragment . The linea ri z e d pAIOCAT wa s blunt e nded and t h e
deletion derivative sequences of HPVll MCE we r e cloned
upstream of the SV40 prom oter a nd CAT gene to generate t he
recombinant CAT pla smids , pRSl and pKS2.
In order t o make the deletion mutant , pKSJ , the SaII-SmaI
f raqm.ent of p UC19 having HPVll MeE sequences was digested with
Al uI. The Sma I - Al u I frtlqrnent was s Ubjected to p art i al
digest ion with Re a l. BamHI linker was added to the RsaI-Al uI
fragment (nucleotide 776 6-7 8 14 ) on eitht"''C side af ter blunt
ending of the fragment . Th is linker added RsaI-AluI f r agment
was cloned i nto the BamHI site of Bluescript KS (+ ) plasmid.
This Bluescript plasmid was digested with HindIII, blunt ended
and. digested with BamHI. Thi s HindIII-BamHI fragment was
cloned in the vector . The ve c t o r to make the mutant, pKSJ was
s imilar to the one used f o r maki ng the mut a n t s , pKSl and PKS2.
except that the BglII sit e was left with a st i c ky e nd . The
blunt ended HindIII-st icky e nd Ba mHI fragment was c l o ned in
pAIOCAT c ontaining blunt ended Acel and st i cky 8g 1l1 end to
generate the deletion mutant, pKSJ .
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.a......1. Cell culture 0:[ P19 mouse embr yonal carcinoma celie:
The PI9 cells ....e re cultured i n a - HEM med ium con taining
10\ he at i nactivated fetal calf ser um. The ce lls we r e
differentiated by t r eatme nt with 300 nM retinoic acid (RA) as
previously described (RUdnicki an d Mc Bu r n e y, 198 7 ) . Briefly ,
the undiffe rentia ted ce lls were maintained in tissue c ult ure
plates . To differentiate Pig EC cel ls , fi rst t he cells were
washed with PBS and t r yps i n ize d . The t r yps lni ze d ce lls wer e
pel leted by c entrifugation a nd r e s uspended in the a-MEM med ium
co ntain ing 300 nM r etino i c acid i n ba c terial dish plates . After
two days of Lncuoat.Ion at 37°C, the cell aggregates were
seeded into fresh bacteriological p l a t e s at a ratio of 1 :2
with f resh medium containing RA. Two days a f t er second
seeding . t he cel l ag grega tes were col l e c t ed, was hed a nd
trypsinized . The cells wer e then p lated i n tissue c ulture
plates with fresh a -HEM medi um co nta i ning no retinoic acid.
Both undifferentiated a nd RA-differentiated cells were used
for transfection s tudies.
2.......J. Traa8factiap af uncHffertlntiatsd and latinate acU-
d ifferentiated c ells 1
Tranl;lff'\ction was carried out 8 hours after plating the
cells . The transfection was do ne us ing the calcium- phosphate
precipi tation method (Gorman et al . 1982 ) . In short , the DNA
pr ecipitat e was prepared by putting 10 j.lq plasmid DNA i n SOj.l l
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of O.IX TE buffer and 62,.,.1 o f 2M c aClz in a f ina l vo lume o f
500,ul and was mixed s l owl y with 500~1 of 2X HBS (a . 28M
NaCl iO. OSH HEPES; 2.8mM Na,HP04 ad justed to pH , 7 . 1) by
constant bUbbling under nitrogen . The white c loudy pr e cipitate
thus obt a i ned was uniformly added to the cultured plat es in
duplicate . The plate s were i nc uba t ed in 3t COl i nc u ba t or at
37°C . The cells were SUbjected t o glycerol s hock 4 ho u r s a f t e r
transfeet i on using 1 .5ml of 15 \ glycerol made in 2X HBS. The
trans fe c ted undi fferentiated an d RA-di f f erentiated cells we r e
SUb j e ct e d t o glyc~rol shock f or three a nd one minu te,
respectively ..'-fter the glycerol s hoc k, the cells were was hed
three t i mes with serum-free medium t o remove tracea o f
glyceroL The cells wer e f ed wi t h fresh a - HEM medium
containing 10% F e S a n d incuba t ed at 3 7°C . Afte r 4 8 h ours o f
incUbation, the cells were harvest ed .
~ aa r yllltin q the cells and prepa ration or cell l ysate ll
for c a." a s aa ya :
The transfe cted c ells were harve sted 48 hours a fter
trans f ee t i on as de scr i bed (Gorman a t al. 1982) . Th e ce l ls we r e
washed thrice with 2ml of PBS and swirled oc ca siona lly f o r
about 5 minutes at room t empe rature a ft e r t he add i t i on of
Tris-EDTA-NaCl ( 0. 04M Tris HCl pH 7 .4; lmM EDTA; 0.1 5M NaCl ) .
After incubation for 5 minute s at room temperature , the cells
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were scraped by rubber p o licema n and were co llected in
e ppendorf t ube s . The ce lls wer e p e lle t e d by spinning for 30
seconds at 4°C in a microfuge . The su pe r natan t was dis ca r d ed
carefully without d isrupting t he pe llet and the cells were
frozen at - 7 0 °C till they were used .
The frozen ce lls were thawed at 37 DC fo r 5 minutes a nd
resuspended in lOO~l of 0 .25M Tris.Hel (pH 7 .8) . The cell
pe lle t was disrupted bv vortexing . The c a lls were l ysed by
t hree cycles o f freezing a nd thawing. T he lysed cells we r e
then sp un in mi c r ofu g e for 5 minutes at 4°C . The supernatant
was collected i n eppendorf t u bes and assayed fo r CAT act ivity .
!.......i. QIl!9ramphenicol acetyl transferase <CAT) assays:
The in vivo ac tivity of different enhancer- CATconstructs
determined by assaying the Chloramphenicol
Acetyltransferase enzyme present i n ce l l l ysates as per t he
procedure descr i.bed by Gorma n at az , (1982) . The assay
reaction co ntained 20~1 of the mixture of 14ltl 1M Tris-liCl (p H
7.8), 1~1 14[C] ch l or amph eni c ol, 11-1 1 of d i s t illed water, 4ftl of
acetyl coenzyme A mixed with 10fll of t h e cel l lysate , The
tota l assay mixture of 30#4 1 was incubated at 37°C for 1 hou r.
After inCUbation, 0 .5ml of e t hyl acetate was added t o s top t he
reaction. The assay mixture was vortexed for 30 seconds t o
ex tract ch loramphenico l . The organic layer wa s taken out in
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s e parate eppe ndo rf t ube s avoiding the interface a nd dried i n
a vacuua aspirator (Sa v a nt ) . The d r i ed organic l aye r was
d i s solved in 15Jl l of ethyl acetate and vortexed for 1 minute
and then spotted on silica gel t hin layer ch romatography (TLC)
p l at e s. The TLC plates were r un with c hloroform-met han ol
(95:5) . The acetylated and non -acetylated forms were
sepa rated by t h is ascending type of T LC. The TLC plates were
sprayed with Ornni f luor En Ha nce to increase the signal . T he TLC
p lates were exposed t o Kodak X-ray fi l m at - 70 ° C . The
qua ntlt <.t l on of t h e ace t y l a t e d and n on-acetylated for ms was
done after autoradiography by c utti ng the spots and counting
by liquid s c i nt i lla t i on . Data we r e expressed as the percentage
of ch loramphenicol co nver ted t o acetylated f orm against the
n on acety l a ted form . The da t a for CAT a ctivities were expre ss ed
after subtracting t he residua l acety lated f o r m c o u nts of the
SV40 promot e r of pAI0CAT from those of the deletion mutant and
wild t ype CAT co ns tructs .
L.2 lInp.ration of nuc lear e xtracts :
L..Z...!..! p reparat ioD of' nuclei =
The nu c lear extracts were pr epared a ccording to t he
procedure described by He nnighausen and Luban (1987) . About
twenty five lOOmm plates o f undifferentiated cel ls and forty
100mm plates of RA-differentiated cells we re harvested for
preparing nuclear extracts . The cells were scr aped with rubber
5.
policeman and harvested by centrifugation for 1 0· mi n u t es a t
1800 rpm at 4°C in a Sorvall H6-4 rotor. The p e lleted cells
were resuspended in 10 volumes of PBS a nd ce n trifuged once
aqain . The pe lle t ed ce l ls were resuspended in 5 p e llet volume s
of 0 .3 suc r o se in Buf fer A. Buffer A contains 1 0mM HEPES-KOH
(pH7. 9 ) , 1 0mM xcr, 1. 5mH Hge l 1 • 0. 1 mH EGTA , O.5 rnM
dithiothrei t ol (OTT) ,O .5 mM of protease i nh i bi t or -
phe nylmethylsulfonylfluoride (PHSF) an d 2~g/ml each of
antipain, leupeptin a nd pepstatin A. T he p.: lleted cells
resuspended in Buffer A were lysed by 8-12 strokes with a B -
pes t le in a Dounce glass homogenizer and a gain 1-2 strokes in
t he presence of 0 .3-0.4% non idet P-4 0 (NP -40). Completion of
lys i s was moni t e r e d un der microscope and the homoqenate wa s
pelleted by centr ifugation for 10 mi nutes at 27 00 rpm at 4 G C.
The pelleted nuc lei were washed twice in 0. 3 M sucrose in
Buffer A without NP- 40 .
l..t.l........a Nuc lIar extract preparation :
The nuc lear extracts wer e prepared as per the prot ocol o f
Hennighaua e n a nd L uban ( 198 7). The nuclei were r e s usp ended i n
all-glass Do unc e homogenizer in 2 . 5 pe l leted volumes of t he
buffer con t a i ni n g 400mM NaCl, 10mM HEPES -KOH ( p H7.9) , 1.SlUM
MgC1 2, O. l mM ECTA,O .SmM O'M', 5\ glycerol and O.5mM PHSF . The
nuclei were disrupted by 10 s trokes with 8-pestle a nd were
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qe n t ly stirr e d for 30 mi nu t es at 4°C fol l o wed by
ce n t rif u gation f or 6 0 minutes at 3 900 0 rpm in 75Ti rotor. The
su p e r natant was col lec ted and dialysed for 2- 4 hours agains t
50 vo lumes of b Uf fe r c on t ain i ng 2 0 mMnepes-xox (pH 7 .9) . 7 5m'"
NaCl , O. lmM EDTA , O.5mM OTT. 20\ glycero l and 0 . 51\M P KSF. T he
ex t r ac t wa s c leare d b y ce n trifug a tion a t 20 000 rpm fo r 15
lIinutes t o re move t he pre c ipi t at ed mater ia l and some lipids.
The ext ract wa s d i str i but ed i n a l iquots and f rozen at _?o Ge .
The pro tein c o ncentra tions i n the nuclear extracts of b o t h
undifferentiated an d RA-differen tiat ed ce lls were by t he
me thod of Bradford (1976 ) •
.L...Il preparation of radi ol.abeled DNA probe. tor in Vitro
.Y..§..M.ll
Tbe mi nimal co nstitutive enhancer f ragment of HPVll
(n ucleot ide 7657- 7870 ) c l o ned i n to t he XbaI s i te of pUC19
plasmi d was digested wit h se i r; and sear , The SalI-SmaI
f ragment was e lectroe l uted from 1. 5\ agarose gel. The Sa ll
s Lte of the fragment wa s e nd -labeled usi ng
transcriptase a nd a [J2p]dCTP . The e nd -labeled DNA was separated
from t he unincorporated nu c l e o t i des by p ass i ng through
Se p had ex G-50 c olumns . The s epa rated r adio labeled DNA which
was pr e cipita t ed , wa shed, d ried and d Laaofved i n d i s tilled
wa t e r was use d oe a p r obe i n the DNaseI pr otection a ssay.
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The plasmid, Bluescript KS (+ ) having 49 base pairs of
HPVll MCE (nUcleotide 776 6 - 78 14) was digested with Pst! and
BamHI. The PstI-BamHI fragment oon1:ain1ng HFVI1 enhancer
s e q u e nce s (n u c l e o t i d e 7 7 66- 7 8 14 ) s epar a ted and
e l ect roe l u t ed from 6% PAGE. The PstI-BamHI fragment was end
l a b e l ed at BamHI site using r ever s e transcriptase and
o: e2p JdCTP . The r a d i o l a b e l e d DNAwas precipitated at -70°C and
washed thri ce with 70': e t han o l in order to remove the
unincorporated nuc j eo't Idee , The washed radlolabeled DNA was
dried and used as a probe.
For uv c r oss-lin king , a 19 bas e pair oligonucleotide
cl)r r e spo nding to the impe r f ec t NFl palindrome (nucleotide
7776-7794) of HPV 11 was u sed . The two strands of the
ol igonucleotide were annealed as per Kadonaga and Tjian (19 8 6)
en-a nick-translated in the presence of Q(llpJdCTP, 5~
Bromodeo>cyurid in(! (BUOR), nneser , polymeraseI and dNTPs. The
radiolabeled DNA was precipitated at -?O·C and washed thr ice
with 70\ ethanol t o r emove the unincorporated nucleotides . The
washed and dried rad iolabeled DNA was dissolved in disti lled
....ater and use d as a probe i n the UV cros s-linking experiments .
~ competitors used in the gel retardation usay'
The 19 base pair oligonucleotide corresponding t o HP Vll
HCE sequences (nucleotide 7776-7794) whfch is part of the
5'
protected region II wa s used a s competit or . I t has the
i llperfect NFl pa lindrome p rese n t i n the s e qu e nc e , 5 ' -
~ATTGCA~GGTT-3 ' . A 24 b a s e p a i r ol igonuc l eotide ha v i n g
the NFl half site c orresp o ndi ng to the sequence , 5 ' -
GTTAAAAGCATTT~CTAG-3 ' of t h e protected region II of
HPVll MCE (nucl eoti de 7 7 9 3- 78 1 5 ) served as a nothe r com petitor.
The oli gonucl eotide c o rrespo n ding t o J C virus perfect NF l
palindrome 5 ' -TGGCTGC;';i\.GCCA&'~3 ' and t he llIu t ant o ligonuc leotide
of the J C v i rus NFl pa lindrome 5' -G T ACTGCCAGACC./\w3' we re also
used a s compe t i tors in the ge l retardatio n assay. The
compl e mentar y strands o f th e o ligonucleot i des wer e a nn ealed
accor ding t o Kadonaga and Tjian (19 86) . Th e oligonuc l eot i des
were u se d wit hout add i ng any r adi ola bel •
.L.! Protocols :fo r i n v i tro a s sa y s :
.a......L...J. PHaBel proteotion assay '
Th e DNasel p ro t ect i on assay was pe r formed according t o
t he procedure described by He nn i gha u sen a nd Lub an (19 87) . Two
different prot ein conce ntrations ( 5 5/1g and 6S1A-9) of nuclear
extracts we r e used i n t h e DNaseI protection assay to map the
pro tected sequences of t he minimal constitutive e n hancer
(nUcl e otide 7657-7870) of HPV1 1. The nuclear ex tracts p repared
from undiff erentiat ed ( UD) and RA-differen tlated eRA) ce lls i n
a tot a l vo l ume of 50111 bind i n g buf fer (SOmM NaC1, 0. 1mM E..·...'1\.,
20mM H~PES-KOH-pH 7 .5 , O . 5mM OTT , 10% glyce rol) along with lft9
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of poly (dI.dC) were incubated for 20 minutes on ice . About
40 , 000 cpm of the radlolabeled HPVl1 MeE probe was added and
incubated at room temperature for 10 minutes . Later on 21£1 of
a mixture of M9C1 2 and Cac12 was added to obtain a final
concentrat ion of 5mM and ImM respectively. Afterwards, ONaseI
stock solution (2Jl9//l1 in 150mM NaCl and sal glycerol) was
diluted W'lth buffer containing 25mM HaCl, lOmMHEPES-KOH at pH
7 . 5 and O.SmM OTT and used at a concentration of 300 ng for
the probes incubated with nuclear extracts. Two different
concentrations, 16n9 and 8n9 (Fl and F2 in the figure . 7) of
DNase I were used to digest naked probe with no protein added .
The naked DNA probes Fl and F2 served as controls since no
nuclear extracts were added to them. The DNaseI was allowed to
act on the DNA probe for 30 seoonds at room temperature . The
reaction was stopped by adding lOOpl stop buffer (0 .375\ SDS.
l5mM ECTA, lOO~4: NaCI, 100mM Tris .HCI at pH 7 .6) containing
50pg/ml sonicated salmon sperm DNA and loopg/ml pronase . This
was followed by incubation for 15 minutes at 37°C and 2
minutes at 90°C . The. reaction products were sUbjected to
phenol-chloroforrn-isoamylalcol1.ol extraction and ethanol
precipitation before l oad i ng in polyacrylamide-8M sequencing
gel . The gel was dried and subjected to autoradiography.
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~ Ge l r e t ardat i on asaaY I
The gel r etar dati on assa y wa s performed a c cor ding t o the
procedures described p r e v i ouslY ( Hennig hause n and Luban, 1 9 8 7 ;
Chodosh e t az , 1988b) with a f ew modificatio ns. The nuc lear
ex tracts h aving a protein conce nt ration of 5p g ....ere i ncuba ted
with 5/l9 of p o ly (dI . de) (d ouble s tran d ed) in a tota l vol ume
of 15/l1 cont a in i ng 12 mM HEPES- Na OH (p H 7 .9) . 4mMTris . Hel ( pH
7.9) I 60 mM Kel . I mH EOTA, 10 % glycero l , O.6mM DTT and JOOp g/ml
bovine serum a l bumin for 10 mi nute s on ice. About 20,000 cprn
of the end- l a beled Pst l - BamHI fragment of HPVI 1 enhancer
s eq ue nces (nuc leotide 7766-7814 ) was ad ded an d the mixt ure was
i nc uba t ed at JOoC f or 30 minutes. Fo r samples used in t he
c ompetit ion studies, the d i fferent co mpetit.ors were added at
t h e time of adding pr ob e . Nak e d DNA p r obe wi thou t nuclear
e xtracts served as c on t rol . The r e action pr od u c t s were run on
4% po l y a c r yl amide gel e lectroph oresis at 4°C with co nstant
c i rculat ion of buffer (6 .6mM Tris.He! pH 7.5, 3 .3mH sod iull
a cetate a nd lrnM EDTA). The ge l was dried a nd SUbjected to
au torad i ogra phy to d etect the DNA-protein complexes.
This WBS d one according t o the p r ocedu re described by
Chodosh e t al. ( 1986) wi t h slight modi fications . Br i e fl y. t he
b i nding b uf f er as de s cribed i n 2.9.2 . was used for t he
r eac tion . The nuc lear ex tracts o f both UO and RA-
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differen tiated ext racts we r e added at a concentratio n of 6 0/-lq
to the binding buffer alo ng wit h lOJ,t9 of poly (d Io de) i n a
total volume of J 0 fll. About 100. 000 cpm of the n Lc k-
translated a nd BUDR-incorporated 1 9 base pa i r oligonucleotide
probe was add ed to t he r eacti on and i ncubated at 30"C f or 30
minutes . The naked DNA pro b e without n uclear ext racts served
as a c o n tro l . After inCUbation , the r eac t i on mixture was
transfe r red to t he NUNC vial and sealed with sa ran wr ap . The
mi xt ur e was irradiated under a Fot odyne UV lamp (max i mum
emission wave l ength , 3l0nN i maximum intensity, 70000Jlw/cm1)
for 10 mi nut e s . The caC12 concen tratio n i n t he mixture was
adjusted to lOlllH. Th e DNA .....h j ...h w as not bound by pro t ei n s in
t he r eacti on mixture , was digested into mononuc leotides with
O.6/Ag o f ONase I (s i gma ) a nd 1 unit of mi c r ococ cal n u cleas e by
incubat.ing at 37"C f or 30 mi nute s . The reaction p roducts in
wh i ch t he proteins b i nding the p r obe wer e separa ted on 1 0%
sodium dodecyl Bulfate p olyac rylamide gel elect r ophores i s
(50S- PAGE) . Be f ore l o ad i ng the reaction produc ts int o the gel ,
2 X load ing bUf ter ( 25 ml 4X T rls.HC1/SDS pH 6 .8; 2 0ml
glycerol; 4g 50S, 3.19 OTT, lmg b r o mophenol blue in 100ml ) was
added to t he samples and t he sam p les were bo i led for 3
mi nut es. The p r esta i ned p r o t e i n markers of high mol ec u lar
weight r a nge (myosi n heavy chai n -200kd, phosphorylase b 97 .4
k d, bov ine s eruIll alburnin-6Skd, ova lbumin-4::kd, ca r b o nic
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anhyd rase-29kd, t"-lactoglobulin-18 .4kd a n d l ys o Z'yme -1 4 . J kd)
were a lso l o aded in to t he g e l t o d et e r mi ne the sizes of
pr ot eins i n teracting wi t h DNA. After separating the r eaction
pr oducts fo r 16 h our s at room t empe r a t ur e , the g el was dried
a nd subjected t o autoradiography .
CHAPTER 3
RESULTS
L..! Activities af enbancer, of BPVll. BPVU an4 HPV18 i n
undifferentiated and retinoic acid-differentiated
The minima l co nstitutive en hancer fragments of HPV~, l
(nuc leotide 7657-7870) , HPV16 (nuc leotide 7224-7778) and HPV18
(nuc l e otid e 75 08 - 773 8 ) cloned in t he CAT p lasmids (pTl , pT3
and p'ra i , r e s pect i vely ) were us ed for the p r e limi nar y in vivo
studies. Tht: SV40 e nhancer less-CAT p lasmid pAIOCAT a nd the
SV40 e nhancer p l a smid pSV2CAT were used as negative a nd
positive contro l p lasmids , respectively.
PI9 mouse embryonal carcinoma cells were d i f f e r entia t e d
wi th 300n M r e t i no i c acid into a heterogeneous population
co nsisting mostly of Io":'lronal cells and a minor population of
fibroblast-like cells (Jones-Villeneuve et e.z , 1982 ). The
recce btnont CAT p lasmi ds were tested in bot h un differenti ate d
(UD) and RA-differentiated PIg cells in t ransfection assays.
No ne of t he HPV enhancers ....ere active i n UD cells. The
positive contro l plasmi d pSV2CAT wa s act ive at a l ow l e vel in
uo c ells compared to its high activ ity i n RA- d ifferentiat ed
cel ls. Th e enha ncer e l e ments of HPVI I and HPVl 6 were active i n
RA-differentiated cells whe reas the HPV18 enhan cer was active
r ig .6 . Act ivities of the minimal constitutive enhancers of
HPVll, HPV16 a nd HPVl8 i n und i f f e r e nt i a t e d a nd RA-
differentiated P19 EC cells.
UD: Undifferentiated
RA: Reti no i c acid-differentiated
pTl, pT3 and pT81: Enhancer-CAT constructs of
HPVl l , HPVIG and HPV18 respectively .
pAIOCAT: SV40 en hancer l e s s-CAT plasmid s e r v i ng as
negative contro l .
pSV2CAT: SV40 en hancer -CAT plasmid construct used as
'?os it i ve control.
The percentages of CAT activi ties of the plasmid constructs as









CAT activities of HPV enbaocer-Ca 'I' constructs in UD and Ra-dlfferent ated PI9 cells
Status of pTl pTJ pT81 pSV2 CAT pAlO CAT
rransfcctcd cells (HPV I Il (H PVI6) (HPVIS) (SV4 D)
un i.J3 0.99 1.29 13.95 1.0
RA·dif(crcn tiatc d 8.74 9.57 2.76 127.98 1.0
pAlO CAT activity was normali:ed to 1.0 and numbers indicate fold activation above that
level by different enha ncer, of human papillomaviruses 11.16 and 18. pSV2 CAT was the
positive contro l SV·K' enhancer.Cz.T construct. pAlO CAT was the negative control SV40
enhancer less-CAT construct. The results were expressed <IS means of three experiments.
~
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at a l ow level . The activities of dif ferent zeccnbdne nt;
plasmids is sho wn in figure 6 a nd table 1. Tt>":!. ne c e ss ary
ce l lular factors for t h e ac tivity of HPV11 an d HPV16 e nhancer s
are expressed in the RA-dl ffe r en t l a ted cel ls . Th e e s s ential
t r a n s ac t i vati ng factors for t he HPVl a e nhancer may be a bsent
i n t his c ell-type. Another possibil i ty is t hat other
repressing f actors mig h t affe ct HPVla enha ncer function .
The HPVll e n ha nce r was chosen fo r furthe r studies . Th i s
was based upo n the impo r tanc e of the HPVll n on cod ing region i n
the rare cases of ma lignancy where i t was f ound t o be
duplicated . Mor e o ver, the HPVI1 enha ncer consists of different
co nstitutive enhancer elements. Additiona l ly HPVIl ennenc er is
relatively short when compared to that of HPV16 to be used fo r
fu r ther ch a racterization purposes .
L...l Correlation of i n vivo activ i ty of BPV ll MCE wit.h i lll
i n vitro DNA-protein i n t e r ac t i o ns :
I n order to de termine whether RA induced t h e synthesis o f
ce llular factors wh i ch wer e responsible f or the ac tivity o f
HPVII enhancer i n RA-differel'ltiated cells a nd t o c or r Al ate t he
in vivo function wi th t he 1n vitr o DNA-protei n i nteractions,
DNa s e I protection assa y was perf ormed . The resu l ts of DNase 1:
pro tection assay are pr e s ent ed in figure 7 . Th e DNase I
protection assay r evealed fo u r protected r egion s, I-IV, with
RA-differentiated nuc l e ar ex't. r-aot;e . This sugges t s t hat t he
Piq . 7 . DNaseI protection a ssay of the minimal c on s t i t ut iv e
enhancer (Mer:, o f HPV11.
UD: Unditferent iated
RA: Re t i noic acid (RA) -differentiated
Fl and F2 : Na k e d DNA probe i n t he a bs e nce o f nuclear
extracts . DNa s e l used was 1 6ng and 8 nq , r espectively.
and II : I ndicate 55f1g and 65f1g of protein
concentrations of nu clear extracts , r es pective ly and
digested with 3 00ng of DNas eL
Th e protected r e g i on s a re bracketed and de no t ed a s
I- IV. The nucleotide positions of the protected r egion s
















cellu lar f a cto r s after RA-di f ferentiation of PI9 cells bind
t he enhancer regions a t nucleotides from 7732 - 7760 (I) . 777 5-
7809 (II), 7834-7855 (III l a n d 7 8 5 5 - 7 87 0 (IV) .
The criterion f or mapping the protected regions 'Ja G
comparison of t he intensity of the bands in t he pr'eeen.:e and
absence o f prote in ( Fl and F2 i n f i gur e . 7) .
The protected regions I and II are i nteresti ng because
t he f ac t o rs i nduced upo n RA-differentiat lon potentially bind
these t wo regions . The protected regions I I I and I V showed
some protection with UD cell nuclear ex tracts . But l '; t he
protein concentrat ion increased to 65Jl9 , protected region I V
appeared t o be similar bo t h wi th un and RA-differentiated
nuc lear ex tracts.
The four pr otected regions have significant sequence
mot ifs homologous to those s een in the kno wn protein
r e co g nition sequences of ot her viral en hancers a nd cel lular
genes which are p r e s ented in t able 2 . Protected region I and
I V h a ve putative APl binding s i tes homologous t o those
observed in t he HPV18 enhancer (Thierry e t al . 1992) or SV40
P- mot i f s (Hirochika at a l . 1988) . Homol og i e s we r e observed f o r
the s ph -motifs of SV40 enhancer to ""hich TEF-l or TEF-2 bind .
An h omolog ous mot if for HPV16 TEF-2 b ind in g site wa s a lso
obs e r v ed (Hi rochika at a l .1988i Chong a t a l .19911 . Protected
r egio n I has sequence mot ifs homologous to t he bi nd ing sites
observed with t he CEIII element of HPVll which was not
TaJ:Jle.2 . Prote cted s e quenc es of the HPVI Ill'l i nimal constit utive
enhance r u s ing P19 RA- d i f fere nt i a ted nuclear extracts and
the ir ho mology t o k no wn tran s cription f ac t or bindi ng motifs .
The s eque nce mot i f s identit i ed i n the prot ected region s
I-IV a nd their homologous protein r e cognition s eq ue nc e s o f
trans cr ipt i on f a ctors o f o t her viral and cellular origins are
given .
NFl : NUcle ar factor 1 ; API : Activator protein 1 ; TEF :
Transcri ption e nh a ncer fac t or .
The protein rec ogn ition sequences f or API were adapted
f rf )m Hirochika et al. (1988) a nd Thierry e t al. (1 992); for
NFl from de Vr i es at a l . (1 981) a nd Chong a t a l . (1991) ; for
TEF2 f ro,,, Chong et a1 . ( 1991).
Under lined s equen ce s indicate the homologous s pb mot ifs
o f t he SV4 0 enhancer to which TEFl a nd TEF2 bind (a d a pt ed from
Hiroch ika a t al . 19 88 ) .
Wavy line indicates the homologous C! EBP b i nding site of
the prot otype motif ATTGG (adaf,i;ed from Gra v es at aj . 1986) .
Dashed line LncIca tiee t he homologous mot if f or the
nuc lear fac tor I-associated f ac t o r (NFA) moti f o f HPV16 (Cho ng
e t az . 199 1; Dollard et al . 199 3 ) . Motifs with s up e rscr i p t s
'a ' and ' b' a re the f a ctor recognit i on sequences o f CEIII of
HPV11 (Auborn e t a l . 1989 ; Auborn a nd Steinberg , 1991) .
Table2
Protected sequences of HP V 11 minimal constitutive enhancer using PI 9 RA ·differentia ted nuclear extracts






Nucleotide Motifs in the Known factor
numbe r protected sequence recognition sequence
7732-7760 TG ACT AATGTA TGACTAANCGA
(putat ive AP I sitel
SV-40 P- matiO








(Adena virus NFl )
TTOGA
(Adena virus NFII NFl half-site )
III TTAGTAL:iII
~CAATACC
7834..7855 ATGCACA.-\ TA AGGCACATAT
(TEF-2 site in HPV 16)










5V·40 p. monf) ~
7.
i ncl uded i n the MCE (Auborn et al . 198 9 ; Auborn and steinberg ,
19 9 1 ) •
In addition, sequences homologolls to -rucreae factor 1
(NFl) binding site we r e observed fo r the sequences of
protected req ion II (Hirochi ka E1 t a1.1988; Do llard e t al.
1993) . There are an imperfect NFl pal i n d r ome with t he seq uence
5 ' - TGGN6GCCAA- J' a nd an NFl half-site oo t i f , TTGGC p resent i n
the protected region II (Table .2 ) . Th e imperfect NFl
pal indrome has a mo t i f , ATTGe, homologous to t h e C!EBP binding
site (Hirochika et 81. 1988; Nakshatri , 1990; Graves et az .
1986 ; Dollard et a1. 1993) . There i s a motif homologous to t he
nu cle a r factor I - a s s oc i a t e d factor (NFA ) mot i f of HPV16 (Chong
e t e.t • 1991 ; Dollard at e.L , 19 9 3 ) •
.L.1. Tb9 r o le ot protect;e4 regions hi the i n yivo function
of the .nhancar:
To stUdy the functional i mportance o f the p r ote c t ed
regions , de letion mutant enhancer-CAT constructs were t ested
f or t heir a ctivity in UD a nd RA-differQntiated c e l l s .
Mut a nt s , pKSl and pKS2 were not a cti ve in UD cells a nd were
eccIve in RA-differentiated ce l l s . Their CAT ect.Ivf e.Lee are
shown in figure 8.
The de letion mutant , pKSI (nucleotide 77 85-7870 of MCE)
which lost protected region I and t he TGGATTGCA (TGG N6)
Piq . 8 . CAT activities of the de letion mu t a nt CAT c onst r uc t s o f
HPVll MCE in RA-differentiated c ells shown i n relation to the
prote cted regions ob ser ved for MCE.
I - IV: Protected r eq i ons of the wild t ype MCE.
pTl : Wild type MCE-C AT cons t r uc t .
pKSl a nd pKS2 : Mutant enhancer-CAT c ons t r ucts
pKSJ : CAT construct of the protected region II .
CEI and CEIl: Des ignated by other researc h ers for
epithelial cell-specific e xpress ion .
The wild type p Tl and mut ants , pKS1, pKS2 and pKSJ have
a CAT gene driven by the SV40 promoter and the respec t ive
enhancer elements. Th e CAT gen e and promoter are not sh own .
The CAT a c tivi t i e s of pKSl and pKS2 a re averages of three
different experiments a nd are shown r elative to the wild t ype
pT1 activi ty which wa s no r ma lize d t o 100% in t he fir s t s et o f
experiments . The CAT activity f or pI<S3 i s an average o f two
different experi ment s and is shown relative to t he wild type
pT1 activity (13.5%) whi ch wa s normalized (l00%) .
The percentage conversions of CAT s ubstrate were
determim.l after deducti ng r esidual promote r ac t iVity
(acety1ated form) of the nega t ive c ontr ol plasmid pA10CAT f r om
those of wild t y pe a nd mutant c on s t r uc t s.
The numbers i n brackets indicate a verage s of actua l in
vivo activitie s . The r e sidual activities of t he wild t ype and
mutant enhancers in UO cells were calculated to s ho w fo l d































sequence of t he imperfect NFl palIndrome of peceeet.ed region
II gave 93\ act ivity re lative t o wild type pTl CAT activity
( 100\) . It is no t known from these r esu l t s whe t he r the TGGN6
p a r t of the imperfect NFl pa lind r ome which has the
p ot en t i a l C!EBP site is ne ces s a r y for high or l ow activity if
included in the mutant, pKSl. The protected reg i on I havi ng
homologous TEF and API b i nd i ng s e q ue n c e s appears to be not
essential for t h e f u nction o f HPVll MCE s i nce the mutient; pKSl
showed a ctivity c l ose to that of wild t y pe .
The mutant, px s i , even though it lost the 'l'GGN6 sequ en c e ,
stil l showed h i gh in vivo activity compared to wild type . Loss
of pro t e cted region I resu lted in s light reduction of activity
with the mutant , pKSl. But l os s of protected r egion I and II
resulted i n s o t reduct ion of wi ld t ype activity with the
mutant , p KS2 . These results suggest that t he act ive mi n i mal
sequences necessary for the i n vi vo activity of MCE a r e
l oca t ed in protected reg ion II. To understa nd the f unctional
importance of the protected r egion II in detail , further work
was carried out u s i ng th i s fragment .
I n a separate set of expf:riments , the i n vivo activit ies
of the wild type p l asm id , pTl j>o:td the deletion mutant , pKSJ
were tested. The protected reg ion II seque nces i n the mutant,
pKS3 gave 9t activity re lative to wild t ype (:AT acti vity
( 100%) in t he second set of experiments (see panel II in
7.
figure 8) . Moreover, pKS3 gave gO-fold higher activity in RA-
differentiated cells compared to its residual activity in UD
cells. The activtiy of protected region II is IO-fold lower
than that of MCE in ;1A- d l f f e r e n t l a t ed cells. The observation
of 90 -fold higher activity of t he protected region II in RA-
differentiated ceLj s suggests that the induction of cellular
factors and their interactlon with protected region II is
important for the in vivo activity of pKS3 . Hence further in
vitro studies were restricted to the protected region II .
.L....i Identifi c a tion ot f ac t. o r lsi bi~ the p rotected
reg ion II determi ned b y ge l r e tardation a s s ay:
The protected regfun II (nucleotide 7775-7809 of MCE)
with some additional flanking base pairs making a 49 base pair
region (nucleotide 7166-1814), was used as the probe to
identify the interaction of factor (5). since protected region
II has known NFl binding sites (TGGATTGCAGCCAA and TTGGC),
oligonucleotides corresponding to both sites (nucleotide 7716-
7794 and 1793-1815 of HCE) were used as specific competitors.
In addition , the polyoma JC virus perfect Nfl palindrome and
its mutant were also used as competitors.
Protected region II gave rise to an extra DNA-protein
complex with RA-differentiated nuclear exerecee , This extra
complex formation was abolished by the imperfect NFl
palindrome of HPVll, whereas the NFl half-site of HPVIl could
Pig . ' . I nteracti on s of ce l l u lar factors wi th t he protected
region II shown by ge l ret a r d at i o n assay :
Th e 49 base pair protected. reg ion II in t he (nucleoti de
7766-78 1 4) PstI -BamHI t rllqJlle llt of Bl ue s cript XS ( + ) was end
l abe led a nd used liS probe .
Lane 1: N!lked DNA probe wi t hout nuclear extract and
compe tit o r DNA. Lanes 2-1 3: n uc l ear extr a cts were incubated a t
a prote in c onc e nt r a t i o n of 5149 wi th the prob e . Eve n nu mbered
lanes i ndi ca t e u ndi f f e rent i ated nuclear extracts . Odd numbe r e d
lanes i ndicate RA~diff.rentiated nu c l ear ex tracts .
Sho r t da r k arrow indicates the extra DNA-pr ot e in comp lex
obser ved with RIo-d ifferent iated n uc l ear ext racts . Lo ng arrow
indicates the un bound tre e probe.
Competi tors used : Lane s 2 and 3 : without comp e tit or .
La nes 4 and 5: HOl'l01090US unlabeled DNA ( PstI -BamHI fraqaent) .
Lanes 6 and 7 : o ligo nucleot i d e 5 ' - GTTAAAAGCA'1'TI"M'GG C'M'CTAG-J '
cor r espo ndi ng t o the s eque nc e s ot protected region II
(n ucleo t i d e 7 7 9 3 ~7 8 15 ). Lanes 8 and 9 : Olig o nuc l e o tide 5 ' -
TGCArrGCAGCCAAAGGTT-3 ' corre sponding to the iIIpe r f ect NFl
pal i ndrome (nucleot ide 777 6- 77 94 ) ot protected reg ion II .
La nes 10 and 11 : Olig onuc l e otide f or t he J C vi rus perfect NFl
pa l indrome 5 ' -TGGCTGCCAGCCAA-J ' a nd its mutant o ligonucl eotidol
with 5 ' -GTACTGCCAGACCA-3 ' i n the l a n es 12 and 13 . The
c omplementary o ligonucleotides were a n nea led and t he cold







not co mpete for t h e extra complex . Sim ilar t o t he NFl half-
site c o mpetit ion , t he NFl p a lind r Oille o f JC v i rus and i ts
mut ant sequence could not abolish the formation of the co mplex
( Fi g . 9 ) . This suggests that the extra DNA-pr ot ein co mplex
observed f o r protec ted region II wi th RA-differentiat ed
n uclear extracts wa s du e t o the effective b i nd i ng of the
c omplex to the HPVll imperfec t NFl pa lindrome (nuc leotide
7776-7794) b u t no t to the seq uences ( nu c l e otide 77 9 3- 7 8 15 )
hl!lv ing sph, ~JFA and NFl hal f - s i t e s . The resu lts a lso indicate
t hat the RA-induce d P19 cellular factor(s) that bind t h e NFl
s i tes of HPVll MeE do not recognise the parfec t Nfl
pa lindromi c sequences of J C vir us . The e xtra DNA-protein
complex not i c ed wi t h RA-differen t iated nucl e ar ex tract s was a
s pecific co mpl ex as it wa s abolished on ly by the h omologous
sequence , bu t not by unre l ated mut an t JC v i r us NFl sequence ,
i n t he c ompetition s t udies .
Ove rall , the r eSUlts sugges t that t he f actor (s )
i nteracting wi t h the imperfec t Nfl p a lindrome ap pea r t o be
responsible for the in vivo ac tivity of the delet ion mutant ,
pKSJ . uv cross-linki ng wa s pe rfo rmed t o f ur ther identify the
p r ot e ins i nteracting wit h the imperfect NFl palind rome .
L.A Proteins iDteracUng with t h t i mp erf ect NFl
palindromic sequences as shown by uv cross-l inking :
Since t he RA-induced f a ctor (s) f o rming ext ra DNA-prote in
Pig-ol0. Proteins of undifferentiated and RA-differentiated
nuclear extracts interacting with the imperfect Nfl palindrome
shown by UV cross-linking.
The o.j.LqonucIeot.Lda corresponding to the imperfect NFl
palindrome was nick-translated in the presence of a [ l1PjdCTP
and BUOR and was used as probe .
F: naked DNA probe without nuclear extracts. The free end
of the probe ran into the buffer and can not be seen .
UOJ Undifferentiated nuclear extracts.
RAJ RA-d ifferentiated nuclear extracts .
F, UO and RA samples were exposed to lTV light , digested
with ONaseI and micrococcal nuclease and run on 101; 50S-PAGE.
The numbers on the right indicate the prestained protein
markers of high molecular weight range loaded into the ge l.
The 14 .3 kd marker ran into the buffer .
Arrows indicate the different sizes of proteins obse rved










c omplex are spec if i c for HPVll im pe rfect NFl pa Lf nd r oae , UV
c r oss-linking was u nde r taken to further ccnr I ra this result.
At least six dif!erent pro t eins o f 60, 56 , 46 , 43, 40 a nd
35 kd int e r acted with t he 19 base pai r NFl oligonucleotide.
Th re e of t hese proteins , with .olecula r we ights of 56 , 4 6 and
3 5 kd ( F l q. l 0 ). were s pecific f or RA-d H f e r e n t iated n uc lear
ex trac t s.
CHAPTER 4
DISCUSSION
Th i s study was undertaken to investigate the in vivo
acitivi ty of the HPVl1 mi nima l constitutive enhancer (He El in
Pl9 Ee c e lls and its correlation wi th in vitro DNA-protei"
interactions was fulfi lled . The identification of mi nima l
sequences t hat reta i n t h e act i vity co mparable to that of wild
type sequences was f acilitated by the mutants used i n this
s t Ud y. A 9 case pair s e qu ence of protected region II was not
i nclu de d i n the mi n i ma l s equences that showed act i v ity wi th
the mutant , pKSl. Hence further studies a re needed to examine
whether i ts inclusion wou ld really elevate the activity o f t h e
i dent i f i e d minimal sequences of this study . The 9 base pair
seque nce (TGG No>. along with the act ive NFl recognition
sequences of the identified minima l sequences wh i ch form t he
protected r e g i on II . was t este d a nd found t o be ac tive by
itself . The correlation of in vivo activ i ty of protected
reg ion II sequences wi t h the in vitro DNA-protein interac tions
was do ne . The identification of t he type of proteins and t h e ir
respective bindi ng sites wi t hin t h e protected region II
sequence s require additional studies . The s e were not the
object!ve s of this s tudy .
8 •
.L...! Difterepoes o b s erved tor t he _DIu .Deer a c H v i ti " o r
BllLin RA-differentiated ce lls:
The three HPV enhancers used in this study we r e not
active in undifferentiated cells. The constitutive enhancers
of HPVll and HPV16 were active in RA-dlfferentiated c ells bu t
t he HPVla enhancer was active only at a low level. Th~ s result
was somewhat s urprising be cause the HPVl8 e nhancer wa s found
to be active i n a neuroblastoma cell line (Swift e t e.z . 198 7) .
The HPVIB enhancer i s known to s bow nar r ow cel l type
specificity since i t can be active only in some cervical
c ar c i noma cell lines but inactive i n others (Swift e t a1 .
1987 ) . This s uggests t hat certain tran s activating f ac t o r s
required t o s uppor t the ttsvia e nhancer activity in P19 EC
ce l ls may be limiting or other r epressing factors may dominate
the scenario . Another possibility Is that t he RA-
differentiated neeercqenecue cell population co nta in limi t e d
numbe r of cells which can su~port the HPV18 enhancer function .
In HeLa ce l l s t he Ubiquitous transcription f ac t o r , Oc t - l
represses the enhancer function of HPVla (HOppe-seyler a t al .
1991) . Hence Oct-l Inay repress the HPVIB enhancer activity in
P19 RA-differentlated c e l l s ana logous to HeLa ce lls.
Al ternatively, the potential NFl binding s i t e s hll.ving GCCAA
sequence are absent in the minimal c ons t i t u t i ve enhancer
fragment of HPV18 used in this study. Hence it i a likely that
t h i s f ac tor might be important for the enhancer fu nction of
. 7
"PV I8 i n PI9 -RA differentiated cells. I t ha s been we l l
docUlllented t ha t t h e f un c t i on of HPVla enhancer mos t ly depends
on the !!.Pl family :members (Thierry at 811 . 1932) . It Is
possible t ha t r e t i no i c ac i d r ecept ors i n t he RA- di!!e r e ntiated
cells 1l1goht i nterfere wi t h the API -depende nt a c tivit y , a fact
wel l documented usin g different c e ll type s (Sch u te a t ar ,
19 91 ; Ni c h o lso n at al. 19 9 0 ) .
The HPVI1 a nd HPV1 6 e nh a nc e r s ware almost equally a c t i v e
i n the RA- diffe r ent i ated cell s . HPVIl e x h i b i ts certa in
fea t u r es , for example , dup lication of the HPVI l NCR I n r are
case s o f malig na ncy (Byr ne et a l. 1987 ) . Moreover, t andem
d u p licat ion o f p a rt o f NCRof HPVI l ....as al s o observed in cases
of nasal inve r t ing pa pilloma (Res pler a t e r , 1987 , Pater at
d . 1988). The NCR part that was f ound du plicated i n t he abo ve
cases include the HCE use d in this s t Udy . Add i tiona l ly , t h e
fu nctiona l pa t terns o f the c o ns titut ive en hancer eteaents , e El
llnd CEIl in eL lIs ot ep i thelial origin were d iff ere nt
(Hi roch i ka at al. 198 8 ; Ch i n at a l . 198 9 ) . 'rnec e fea t u res
s ug ges t that t he mi nimal co nst itutive e nha ncer (HCE)
co nsisting o f bo t h eE l a nd CEIl mi gh t be f unc tiona lly
imp orta nt f or t ranser ipt ionllli r egulati on i n the context o f
ot he r ce l l t yp e s also . These ch ar ac t e r i s t i c s of HPVl l pr ompted
t o u nder t a ke further studies with HPVll min imal
co ns t itutive e nhance r (HeE).
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J.......1. PQr n lat!o D o f in v i Vo activ Hy of HPV U H~
in vitro PNA-prot ein interactioDs;
The minimal cons t i t u t i ve enhencex of Hf>Vll requi r ed for
RA di fferentiati on -dependent act i vity in PI9 Ee cells was
found to be p r ot e c t e d at four different regions (I-IV) i n a
DNase l protection assay . Reg ions ~ and II were ex clusive ly
protected wi t h RA-different iated nuclear extracts but not with
UO nucle ar extracts . Regions III and I V were al s o prote c t ed ,
a l be i t to a l esser extent, with und i fferent i ated nuc l e ar
extracts . Since the factors i nduced by r etinoic acid
specifically bind regions I and II, it was thought that e ither
or both of these two regions might playa major role i n the RA
differentiation-dependent funct ion of the HPVl l MCE. The
pr ot e c t i on i mpr ov ed for reg i ons III an d I V whe n i nc r e ased
protein con centra tion of RA-differentiated nuclear extracts
was used . One can speculate that the fa ctor s b i nd i ng t he s e
regions might undergo some modifications like phosphorylation
or that extra f ac t or s are i ndu ce d by RA-diffen:,ntiation .
A number o f protein bi nd i ng motifs are present f or the
known t ransc ript ion factors in al l fo ur protectb j r eg i ons
(Tab le . 2) . The po ssible roles o f ea ch of these bind ing s i t es
and functional eocper'at.Lcn among them in t he c ont e xt o f
mi nimal co nstitutive enhancer and mutant enhancers i s
discussed in 4 .3 .
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.!..::..1 Fun otional im portance ot t he pr ot ected r egions:
The f unctional importance of the prote cted regi o ns which
ne ve different protein recognition motifs was confirmp-d by
testing the in vivo activit ies of the deletion mu t a nt s of the
mi nimal constitutive enhancer of HPVll. The de letion mutant
pI<Sl , without protected region I and t he TGGATTGCA part of the
i mperfect NFl palindrome of protected region I I . d isplayed
act i v i t y c lose t o t h a t or wild type NCE pla sm id, pTl. De l e t i on
of protected reg ion II al s o r educed the wild type activity t o
50\ as obs e rved with the mutant , pKS2 . This suggests that a
l o t of NCE act! vity is c ont ri bu t ed by the seque nc e s located i n
protected regio n II .
Protected region II alone was not responsible for the
activitie s of both pTI and pKSl because the down stream
protected reqions III and I V i n pKS2 a lso exhibited 50% of the
wild type activity . More over , there va s marginal loss of
activity with the deletion mutant , pKSI a s compared to that of
wild type. This c a n be attr ibuted to e i t her protected region
I or to the NFl half-site TGG or t he po t ential C/EBP motif of
the deleted imperfect NFl palindromi c sequences of protected
region II. In contrast , drastic lOGS of activ ity of t h e eE l
e l eme n t i n pr imary kerat inocytes was observed whe n the C/EBP
motif o f t he imperfect NFl palindrome was d i s r upt e d (Dollard
a t ~1 . 1993) .
Th e functional role of r e g i on I in t h is s tudy appears to
9.
be negligible although it ...as pro t e c t e d exclusively with RA-
d i ffere n t i ated n uc j e ex e xt r a c t s . I n a simi lar fashion ,
s equences corresponding t o the protected region I o f MCE of
thi s stUdy wer e found i nteracting wi th t'act ot-s of othe r cell
types and such i nteractions disp layed no f unctional role
( Dol l a r d et al. 19 9 3 ) a na Lcq cu e t o t h i s s t udy. He nc e cellular
f actors binding t o the dif ferent prote c t e d regions e s p e c i all y
r egions II , III and IV appear to fu nctionally ..::ooperate with
e a c h oth e r t o give th e activities o f pTl and pKSl. The
fu nc tiona l cooperation among f actors binding to regions II I
a nd I V mi ght be r espo ns ible f or t he in vivo actIvity of pKS 2 .
Functional coop eration wa s suggested to be essentia l for t he
activatio n of a 91 base pa i r e p ithe lial cell-specific enha ncer
of HPVI 6 . Su c h a transcription factor syne rgism ha s been
pro posed for othe r HPV enha ncers as we l l (Cho T'g a t al. 1990;
chong et al . 19 91 ; Apt et al. 1993) . Similarly, transcriptio n
factor s y nerg ism ca n be a ttributed to the factors binding t he
pro t e cted r egions t o gi ve fu ll MeE activ i ty an d t h e activ i ties
of mu ta nts a s we ll.
Di f f erent factors such a s eTF/NF1 , AP1 a nd TEF are
pos sible ca ndid ate transcription factors to interact wi th
their respec t ive r e cog n i t ion sequences observed i n the
prote cted r eg i on s . There were homolog i e s observed fo r CTF/ NFl
f or some o f t he sequences o f protected r egion 1. Similar
s e q ue nc e s in the CEIl I e lement of HPVll were fou nd to i nteract
9 1
....ith u nidentif ied factors (su perscript ' a ' i n t ab le 2)
p rev ious ly s how n ( Auborn at al. 1989; Au born a n d steinberg ,
199 1) . The f unctional i mporta nc e of such ce l lular facto r
i nteractions needs further i nves t i gat ion .
If API is p r e d i cte d to bind t he p utat i v e mot i f s i n
protec ted r eg i ons I , II a nd I V, ret i no ic ac i d receptors migh t
interfere wi t h t h e API activi ty as observed with othe r cell
types (Sch l ue et a l . 1991; NicholsOll e t al . 199 0) . But some
RA- ind uced API - Ilke f ac t o rs , for example , PEA- I , we r e ob s e r ved
t o bind the ' P ' motifs of the pol yoma en hanc e r s in F9
embryonal carcinoma ce l ls (Kryszeke at 091. 1987) . There is a
possibility that API -like factor s in RA- differentiated PI 9
cells can bind the homo l ogou s 'P' motifs or put at i ve API
mot i f s of the protected regio ns .
The other poss ib le t r an s c r i ptio n factors that b i nd to
different protected regions include TEFl a nd TEF2. The
seque nces ho mol og o us to TEFs are l o cated i n t he prot e ct ed
regions I , III a nd IV. Th e r ole of NFl b indin g sites l ocated
in t he pro tected r e g i on I I i n t he t r a ns cripti onal activation
o f HPVll ca n not be exc Lu d ed , The NFl pro t e ins b i nd ing to the
protected r egion :II may coo p erate with o ther transcript i on
factors t,c h as TEfl o r TEF2 t o confer maximal in vivo
activi ty of HPVll HCE.
The ac tivities of p Tl a n d pK5 1 a ppear to d ep e nd upon
functional cooperation among t he pOE'<:I ible t r a nscript i on
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factors as d iscussed above . There h: a possibility that APl-
lik e f a c t or s and TEFa bind to their respective motifs in
protected regions I t II I and I V. This leads to the functional
cooperation with NFl factors binding the protected r egion II
to give full MeE activity. Similarly, either TEF or APl-like
factors or a combination of both may bind the protected
regions III and IV Which, i n turn , can cooperate with the NFl
factors binding the protected region II leading to pKSl
activity. Additionally , possible functional synergism can be
attributed to the activity of pKS2 . It might depend upon the
interactions o f TEF and API-like factors or TEFI-TEF2 with the
protected r egi o ns III and IV.
A TEFl-dependent coactivator was found to be important
for transcriptional activation from HPV16 e nha n c er (Ishi ji et
al . 1992) . There is a possibility that s uch a coactivator may
exist 1n RA-differentiated P19 cells supporting the po ssible
TEF-mediated activation for the mutant, pKS2 in particular.
TEFl was f ound to activate by means of a un Lque TFItD complex
(Brou et at . 1993). Hence it is quite po ssible that such
unique subsets of TFIID that i nt e r a c t with NFl ('Jr TEF might be
present or induced in P19 cells leading to the activation of
wild type and mutant HPVII enhancers .
9 3
L.J. Corrtl.tion of in yl yo activity of prot,ct,4 [.gioD II
....xllI! in v :ft:ro DNA-protein interactions :
The mutant pKS1, cons isting of p art of t he pr otecte d
region II, ex hibited in vivo ac tivity clos e t o t hat of wild
type . Since a 9 ba s e pa ir s e quence of t he prot ected r eg ion II
was no t i nc l u d e d i n pKS2 , i ts functional ro le c annot b e
deduced from this s t udy . Since t hr e e - f our ths of pr otect ed
region II was responsible f o r the i n vivo ac t i v i ty (pKS l) t he
fu nc tional importance of the complete protec ted r egion II
a lone was examined us ing i ts de letion mutan t - CAT pla s mid ,
pKS3 . The protected region II having NFl sequ ences g ave 9\
activity re lative to that of wild type MCE (100%) i n a
different set of ex periments .
The act!vity of protected region II was l O- f o ld lower
tha n that of wild type MCE . This result wa s no t s urprising
since a nalogous observations fo r the activities of HPVl 6 NFl
sites or HPVll NFl si tes i n other cej.L t ype s were repor ted in
previous stUdies . The wild t ype Dr al- DraIlI e nhancer f r agment
ha v i ng tw o NFl motifs o f HPV16 gave 10.2% CAT activity
re l at ive to t hat of parent vector alone (Apt et ez , 199 3) .
Mor e over, t he ac tivity given by a simi lar t yp e of e nhancer
fragment of HPVl 6 (nucleotide 7675- 7755) h av ing two NFl sit es,
TEF a nd NFA motifs, wa s on ly 2 .2-% re lative to that o f paren t
vector in HeLa cells (Chong a t al . 1990). In thi s study, t he
ac tivity of the protected r eg i on II having an imperf e ct Nfl
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palindrome , hOlllologous NFA motif and an NFl half-site was 9\
after SUbtracting the activity of negative control (parent
vector) •
Moreover, the activity exhibited by the protected region
:II in RA-differentiated cells can be indirectly compared with
the activity of same sequences of HPVll in keratinocytes as
shown by Dollard at al. (1993). A tetramerized fragment
corresponding to the sequences of protected region II
displayed 60% CAT ;Jctivity relative to that of wild type eEl
(approximately 30\ CAT conversion) in primary keratinocytes
(Dollard et 61. 1993). The activity shown in primary
keratinocytes might be still less if a monomer was used.
The activity given by protected region II jn RA-
differentiated cells was gO-fold higher compared to its
residual activity in UD cells. Hence it is pceeIbj.e that the
cellular factors responsible for the in vivo activity of
protected region II (pKS3) were induced by retinoic acid in
PI9 cells. The RA differentiation-dependent activity of
protected region II sequencer. was further correlated with the
binding of RA-induced cellular reccce re) •
The sequences of protected region II were found to
interact with specific cellular factor(s) induced by RA-
differentiation. This was detected as an extra DNA-protein
complex in the gel retardation assay . Hence the RA
differentiation-dependent activity of the deletion mutant pKS3
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appears to be due to the i nteraction of RA-induced factors i n
a sequence-specific manner .
The possibility of interac tions of cellular factors with
the sequence containing NFl half-site TTGGC was ru led ou t
since t he o ligonucleotide co rresponding to this motif of HPVl1
Me E did not compete for the extra DNA-protein comp lex formed
by the protected region II . Since the hperfect NFl palindrome
located in t he protected region I I only abolished complex
formation, the factors induced upon RA-differentlation appear
to b ind s trongly to the imperfect NF l palindrome .
The factors that interact with t h e imperfect NFl
palindrome are specific for HPVll since JC virus perfect NFl
palindrome and its muta nt could not compete f or the extra DNA-
protein complex formed with the RA-differentlated nuc l ea r
extracts. This suggests that t he cel lular factors induced by
RA-differentiation bind the pe rfect and imperfect NF1
pa lind romic sequences differentially . This is quite
informative because factors bind ing the NFl seq ue nces show
different binding s pecificities (Chodosh et ez, 19 8 8a i Chodosh
et e r , 1988b) . Moreover, r ec e nt s tudies have shown that t he
f a c t o r s in RA-differentiated Pl9 ce l ls , binding the imperfect
and perfect NFl palindromes of JC vir us, are probably
different (Kumar at .!Il. 199 3 ). This further confirms the
existence of a fam ily of NFl proteins th at ex hibit different
binding apec Lf Ic Lt.Lea ,
9'
The oligonucleotide h a vi ng the NFl h a lf-site a nd
homologous NFA motif did n o t abolish the f ormat i o n of t h e
ex t ra DNA- protein comp lex when RA-differentiated P19 EC cell
nuc lear e xt r acts were used in the ge l retardation assay
(Fig .9). But some of t he nucleotides corresponding t o the MFA
motif were f ound protected in the DNase! protection as s a y
(Fig .7). Th ese different findings regarding the interactions
of cellular fa ctors with the NFA mo t if i n the 1n vitro assays
ca n be explained as f ol l ows . DNas::.L protection assay i s a more
direct way o f showing sequence-specific interactions
(He nnighaus(j:n a nd LUba n , 1987) . Mo r eover t he cellular factors
interacting with t he NFA moti f may be re lative l y tow i n
abundance and whose binding may be detectable b y DNaseI
protectio n assay rather than by the gel re tardation eaeey ,
Th i s cou ld be d ue to a h i ghe r concentration of DNA a nd protein
us ed in the DNase! protection assay compared to the g e l
retardation assay . Alternatively, cooperat ive b i n d i ng o f
factors t o the i mper f e ct NFl pa li.ndro me and NFA is possible
and this cannot be addressed by the type of co mpetitions
pe r f ormed in th i s gel retardation assay.
As the RA-differentiation-specific complex
effectively competed by t he imperfect Nfl palind rome , uv
cross-linking was carried out in order to con firm this
observation and to f ind out the size of the p r ot e i n (s). six
di f ferent p r ot e i ns wi t h molecu lar we ights ranging from 35- 6 0 kd
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were c r oss li nk e d wi t h the NFl oligonucleotide . Three of them
of 56, 4 6 and 35 k d were observed exclusively with RA-
differentiated nuclear e xtracts. Hence further s t u d ies are
required t o determine the f unc t i ona l importance o f these
proteins compa red to the common proteins of UD and RA-
di f ferentiated cells . Moreover, further studie s s hou l d be done
to find out whic ;l of the three proteins bind t o the NF1 mot i f,
GCCAA and i ts 3 ' fl anking nucleo t i d/ils and new i mpo r t a nt this
i s in terms of the in vivo ac t i vity of t he deletion mutant,
pK S l.
Furt he r s tudies a re to be done t o investigate t h e r o l e s
of the different i d e nt ifie d proteins f o r t he expression of
protected r egio n II in Pl9 EC cells.
FUTURE STUDIES
The results of t his stUdy suggest t he i mportance of
imperfect NF l pa lidromic sequences in tt-e act.Lvet.Ion of the
protected region :II in P I9 RA- differentiated cel ls . It h a s to
be precisely studied whether NFl. mo t i f has a role i n the
activi.tyof protected region II . The functional significance
of the motifs , TGG, C!EBP motif. Nfl mot i! GCCM and NFA motif
\<Ii11 b e c lear ly established only after lIIut"'ting t hem by s ite-
directed mutagenesis and testing the muta nts for thei r in vivo
activity. Mutating the NFA mo t if would definitely confi r m
whether the protein interacting with GCCAA motif extends i t s
ccne a c e e i nto the nuoleotides of the NFA motif o r a different
facto r interacts with NFA mot i f .
T he precise binding site among t he obser ved factor
bindin g motifs of the imperfect Nfl palindrome important for
functional activity can be de t e r min ed only after testi ng the
site-directed mutants for t he i r activities . Using UV-cross-
linking, it will be ;<nown whic h one o f t he proteins out of the
three ide ntified RA-diffnentiated proteins , binds the
functional protein binding site. once it is c learly
established, the isolation of p r ot e in and eubeequent c loning
of t he fac tor can be achieved.
Using t h e factor b i ndi ng site , the eDNA e ncoding that
fact or can b e i s o lated f r om RA-differentiated eDNA library
••
e mpl oy ing s out hwest ern bl ot ting a s say . If the factor
i nt era c tinq wi th NFA t o b e c lo ned is of i nt e rest . the i solated
f actor can be comp a r ed with known pr oteins of Oct f amily s i nce
NFA shares h o molog ies with t he octamer bin ding s e qu en ces . I f
the fac t or t o be i s olated is the one whi ch i nt er acts with the
GCCAA motif , then the iso lated factor has to be compared with
k nown members of NF l family. If it i s a me mber of NFl family ,
using the c DNA encoding NFl, c Olllplement ati on assays can b e
performed i n order to k n o W' whether it can t ransact i vate not
o nl y HP Vll NFl bi n ding s i t es but also Nfl s i tes of other HPVs
in RA-d if feren tiated and undifferent i ated PI9 c ells . In a
s illlilar fashion, on e can s t udy Whether the cl o ne d NFl ca n
c ompl e ment the activ i t y o f HPV11 enhancer in epi t h elia l cells,
p ar tiCUlarly of primary nature .
u s in g s q uelch ing e x perime n t s W'ith t h e cl on e d eDNA, one
can s t Udy the exi s tence of a coact ivator bridqing the factors
binding the NFl sequences of protected region II i n P1 9 RA-
d iffe r e ntiat e d ce l ls .
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